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EFFECT OF ELK1 AND YY1 TRANSCRIPTION FACTORS ON SPG4 AND 
KATNB1 PROMOTERS 
SUMMARY 
Cytoskeleton is an important network for cellular processes such as mitosis, 
cytokinesis, cell shape and motility. The cytoskeleton consists of three types of 
polymeric fibers: intermediate filaments, microfilaments, and microtubules. 
Intermediate filaments provide cells mechanical strength, such as keratins in 
epithelial cells and neurofilaments in neurons. Another component of cytoskeleton, 
actin microfilament, is involved in various cellular functions such as contraction of 
muscles, maintenance of cell shape. The last member of the cytoskeleton is 
microtubules. Microtubules are very dynamic structures and they have active roles in 
cell division, cell morphogenesis and intracellular organelle transport. The dynamic 
structure of microtubules is provided by two mechanisms. One of the mechanisms is 
dynamic instability, rapid polymerization and depolymerization; the other 
mechanism is cleavage of microtubules by microtubule-severing enzymes.  
Microtubule-severing enzymes katanin and spastin are members of AAA super 
family of ATPases. They severe microtubules into shorter polymers which are 
essential for neurogenesis. Although both of these proteins are microtubule severing 
enzymes and their mechanism of action is similar, they cut microtubules in different 
legths. Katanin is composed of two subunits: p60 subunit contains AAA ATPase 
domain, which severs microtubules and non-ezymatic p80 subunit which enhances 
severing activity of p60. Katanin is highly expressed in nervous system and its 
inhibition or overexpression impairs axon formation. Furthermore, mouse model of 
Alzheimer’s disease showed that katanin levels in hippocampus of transgenic mice 
was less compared to wild-type mice.  
The other microtubule-severing enzyme, spastin is encoded by SPG4 gene and 
mutation in SPG4, causes Hereditary Spastic Paraplegia disease. Studies showed that 
wild-type spastin overexpressing cells have disrupted microtubule network. It has 
been shown that downregulation of spastin caused morphologic undergrowth, 
reduced synaptic area, and increased synaptic microtubules by in vivo experiments. 
Conversely, overexpression of spastin reduced the synaptic strength and amount of 
synaptic microtubules.  
Transcription factors YY1, a GLI-Kruppel class of zinc finger protein, and Elk1 Ets 
family of transcription factor are able to contribute both in activation and repression 
of the target gene and are ubiquitously expressed in different tissues as well as in 
brain.  
Our aim in this study was to identify the regulation of SPG4 and KATNB1 gene 
expression by Elk1 and YY1 transcription factors. The optimal promoters of 
KATNB1 and SPG4 have been previously identified by our laboratory. For this 
purpose, we started with analyzing the binding of these proteins to the corresponding 
promoter regions. For this purpose, we performed EMSA by using oligonucleotides 
including related transcription factor binding sites, which are predicted on SPG4 and 
xx 
 
KATNB1 promoter and confirmed the binding of Elk1 and YY1. To further confirm 
the specificity of the binding, we produced  recombinant Elk1 and YY1 proteins that 
contain only DNA binding domain and performed supershift assay by using these 
recombinant proteins. 
To investigate regulation of SPG4 and KATNB1genes by YY1, different YY1 
constructs, which lack of activation or repression domain were obtained. The results 
demonstrated that YY1 act as a repressor on both KATNB1 and SPG4 promoters. It is 
known that SUMOylation can make a transcription factor to act as a repressor. So 
that we mutated YY1’s SUMO binding site in order to obtain SUMO defficient YY1 
transcription factor and to explore the function of SUMO modification on YY1. 
Luciferase reporter assay results showed that vast majority of repressor function of 
YY1 is due to its glycine/lysine rich domain rather than SUMOylation. 
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ELK1 VE YY1 TRANSKRİPSİYON FAKTÖRLERİNİN SPG4 VE KATNB1 
PROMOTORLARI ÜZERİNDEKİ ETKİSİ 
ÖZET 
Hücre iskeleti, mitoz, sitokinez, hücreye şeklinin verilmesi, hücrenin hareketi gibi 
mühim faaliyetlerde görev alan önemli bir ağ yapısıdır. Hücre iskeleti üç temel 
polimerik yapıdan meydana gelir. Bunlar ara filamentler, mikrofilamentler ve 
mikrotübüller olarak adlandırılırlar. Sinir hücrelerindeki nörofilamentler ve epitel 
hücrelerindeki keratin ara filamentlere örnek verilebilir. Bu yapılar hücreye mekanik 
dayanıklılık kazandırırlar.  
Hücre iskeletinin diğer bir üyesi olan aktin filamentler yani mikrofilamentler, bir çok 
hücresel işlevde görev alırlar. Başlıca fonksiyonları, hücre şeklinin korunması, 
sitoplazma yoğunluğunun sağlanması, organellere tutunma yüzeyi hazırlanması ve 
kasların kasılmasını kontrol etmesi olarak sıralanabilir. 
Hücre iskeletini oluşturan diğer bir yapı ise mikrotübüllerdir. Mikrotübüller temel 
olarak hücre morfolojisini, hücre bölünmesini ve hücre içi organel taşımasını 
sağlarlar. Mikrotübüller oldukça dinamik bir yapıya sahiptirler. Bu dinamizmi 
sağlayan iki mekanizma vardır. Birincisi intirinsik yol olan “dinamik instabilite” yani 
mikrotubullerin hızlı bir şekilde polimerizasyonu ve depolimerizasyonudur. İntirinsik 
mekanizma α-tubulin ve β-tubulin heterodimerlerinin büyüyen ve kısalan mikrotübül 
zincirine eklenip ya da ayrılımasıyla meydana gelir. α-β heterodimerleri bir ara 
geldiğinde GTP hirolizi gerçekleşir ve böylelikle mikrotübüllerin gövdesi GDP bağlı 
tübülin dimerlerini barındırır. Mikrotübüllerin uç kısmında ise GTP bağlı β-
tubulinler bulunur. GDP bağlı tubulinler daha stabil bir yapı oluşturlar. GTP bağlı 
tubulinlerin bulunduğu, hızlı bir şekilde polimerize ve depolimerize olan uç artı (+) 
diğer uç ise eksi (-) olarak adlandırılır. Eğer GTP ucundaki β-tubulin üzerinde 
bulunan GTP başka bir GTP-bağlı β-tubulin eklenmeden GDP’ye dönüştürülürse 
mikrotübüler hızlı bir şekilde depolimerize olurlar. Yalnız GTP-tubulinler sadece artı 
uçta değil microtubul gövdesinde de bulunabilirler. Böylelikle depolimerize olan 
microtübüllerin bu noktalara gelindiğindee tekrar polimerize olması sağanır. 
Mikrotübüller sinir hücrelerinin akson ve dendritlerinde yoğun demetler halinde 
bulunarak bu yapıların uzamasını ve korunmasını sağlarlar. Sinir hücrelerinde 
bulunan mikrotübüller sentrozomlardan çekirdeklenirler ve mikrotübül kesen 
enzmiler aracılığıyla buralardan ayrılarak kısa parçalar halinde sinir hücresinin 
uzantılarına taşınırlar. Bu taşınma mikrotübül ne kadar kısa olursa o kadar hızlı 
gerçekleşir. Diğer bir deyişle taşınma hızı mikrotübül boyu ile ters orantılıdır.  
Mikrotübüllerin küçük parçalara kesilmesi için AAA ailesi ATPaz’larından olan 
katanin ve spastin’e ihtiyaç duyulur. Mikrotübül kesen bu iki enzim nöron 
gelişiminde önemli bir role sahiptirler. Benzer çalışma mekanizmasına sahip olmakla 
beraber bu proteinler microtübüllerin farklı boyutlarda kesilmesini sağlarlar 
Spastinden farklı olarak, katanin iki farklı altbirimden oluşur. Bunlar enzimatik 
faaliyet gösteren ve AAA ATPaz bölgesi içeren p60 ve enzimatik görevi olmayan 
p80’dir. p80’in görevi ise p60’a bağlandığında p60’ın kesim aktivitesini artırmak ve  
WD40 bölgesi ile p60’ı sentrozomlara konuşlandırmaktır. 
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Yapılan araştırmalar sonucu kataninin sinir sisteminde oldukça yoğun olarak ifade 
edildiği saptanmış ve baskılandığı zaman microtübül uzunluğunda artış 
gözlemlenmiştir. Bu artışın ise akson gelişimini olumsuz etkilediği ve ayrıca 
microtubullerin sentrozomlarda birikmesine de sebep olduğu gösterilmiştir. Bu da 
kataninin mikrotübüllerin sentrozomlardan ayrılması ve akson büyümesi için ne 
kadar gerekli olduğunu göstermektedir. Fareler üzerinde yapılan bir deneyde ise 
Alzheimer hastalığı modeli olarak kullanılan transgenik farelerin hipokampüslerinde 
katanin seviyesinin kontrol farelere göre daha az olduğu gösterilmiştir. Buradan da 
kataninin nöronların dejenere olup olmamasında belirgin bir rol oynadığı 
anlaşılmaktadır. 
Diğer bir mikrotübül kesen enzim, spastin, otozomal dominant Herediter Spastik 
Prapleji (HSP) hastalığına sebep olan spastin kodlayan SPG4 genindeki 
mutasyonların incelenmesi aşamasında bulunmuştur. Yapılan çalışmalarda spastin 
proteininin aşırı üretildiği hücrelerde dağılmış bir mikrotübül ağına rastlanmaktadır. 
Spastin seviyesinin düşürüldüğü diğer çalışmalarda ise, bu azalışın morfolojik 
olgunluğa erişimi engellediği, sinaptik boşluğu küçülttüğü ve sinaptik mikrotübülleri 
arttırdığı  belirtilmiştir. 
Bütün diğer proteinlerde olduğu gibi hücre içindeki katanin ve spastin miktarı da 
transkripsiyon mekanizması ile düzenlenir. Bu düzenlemenin kontrolü ise gen 
anlatımını sağlayan promotor bölgelerine bağlanan transkripsiyon faktörleri 
aracığıyla gerçekleşir. Elk1 ve YY1 bunlardan yalnızca iki tanesidir. 
Ets ailesi transkripsiyon faktörlerinden olan Elk1 ve GLI-Kruppel zinc finger 
proteini YY1 hedef genin hem aktivasyonunu hem de represyonunu sağlayabilirler. 
Bu iki transkripsiyon faktörüne beyin de dahil olmak üzere çeşitli dokularda sıkça 
rastlanılmaktadır. İki transkripsiyon faktörünün de fonksiyonunu düzenleyen farklı 
bölgeleri vardır. Elk1 N-terminal DNA bağlanma bölgesine sahipken, YY1 DNA ile 
C-terminalde bulunan 4 zinc finger vasıtasıyla bağlanır. Her iki protein de tranlasyon 
sonrası çeşitli modifikasyonlara uğramaktadırlar. Bu modifikasyonlardan, kinaz 
yolağı aracılığıyla sağlanan serin (Ser, S) ve treonin (Thr, T) amino asitlerinin 
fosforilasyonu, transkripsiyon faktörlerinin ilgili gen ifadesinde aktivatör rol 
üstlenmesine sebep olurken; bir diğer modifikasyon olan SUMOlanma ise gen 
ifadesinin baskılanmasına yol açmaktadır.  
Bütün bu bilgiler bir arada düşünüldüğünde, sırasıyla spastin ve katanin 
proteinlerinin ifadesini sağlayan SPG4 ve KATNB1 promotorlarının YY1 ve Elk1 ile 
nasıl regüle edildiğinin tespit edilmesi son derece önem teşkil etmektedir. Böylelikle 
nöronal gelişimde ve nörodejenerasyonda önemli role sahip mikrotübül kesen 
enzimlerin, YY1 ve Elk1 transkripsiyon faktörlerinin etkisinde miktarlarında ne gibi 
bir değişikliğe sahip olduğu ve bu etkiyi yaparken ilgili transkripsiyon faktörlerinin 
hangi yolaklardan etkilendiği saptanabilir. 
Bu çalışmada, öncelikle SPG4 ve KATNB1 gen promotorlarının YY1 ve Elk1 
transkripsiyon faktörlerinin etkisi altında olup olmadığını belirlemedeki ilk adım 
olan, ilgili gen bölgelerine transkripsiyon faktörlerinin bağlanıp bağlanmadığını 
belirlemek amaçlanmıştır. Bu etkileşimi saptamak için laboratuarımız tarafından 
belirlenmiş KATNB1 ve SPG4 optimal promotorlarında bu iki transkripsiyon 
faktörünün olası bağlanma bölgeleri biyoinformatik araçlar kulanılarak 
belirlenmiştir. Daha sonra EMSA yöntemi ile Elk1 ve YY1’in bu bölgelere 
bağlandığı doğrulanmıştır. Bu aşama sonrasında bağlanmanın YY1 ve Elk1’e 
özgünlüğünün tespiti için rekombinant proteinler üretilmiştir. Elde edilen 
rekombinant proteinler Elk1 ya da YY1’ın yalnızca DNA bağlanma bölgesini 
içermektedir. Elde edilen sonuçlara göre ilgili bölgelere bağlanan proteinlerin YY1  
ve Elk1 olduğu doğrulanmıştır. 
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YY1 transkripsiyon faktörünün SPG4 ve KATNB1 promotorlarına bağlandığı 
belirlenmesinin ardından YY1’ın katanin ve spastinin gen anlatımındaki rolünün 
tayin edilmesi gerekmektedir. Bilindiği gibi YY1 hem aktivatör hem de represör 
olarak görev alabilmektedir. Bundan dolayı YY1’ın aktivatör ya da represör olarak 
görev almasını sağlayan bölgeler çıkarılarak YY1 fonksiyonunda etkili yolakların da 
belirli bir oranda etkisi incelenmiştir. Ayrıca transkripsiyon faktörlerinin represör 
etki göstermesinde önemli olan SUMO modifikasyonu da YY1’in SUMOlanma 
bölgesi mutasyona uğratılarak incelenmiştir.  Sonuçlar göstermiştir ki YY1 
transkripsiyon faktörü hem KATNB1 hem de SPG4 promotorları üzerinde baskılayıcı 
rol oynamaktadır ve bu baskılanma SUMO modifikasyonundan ziyade YY1’in 
glisin/lizin zengin bölgesi ile sağlanmaktadır.  
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1.  INTRODUCTION 
1.1 Cytoskeleton 
Cytoskeleton, a network of protein filaments extending throughout the cytoplasm, is 
critical for mitosis, cytokinesis, intracellular transport, regulation of cell shape and 
cell motility. The cytoskeleton is composed of three principal types of cytoplasmic 
fibers: microfilaments, intermediate filaments and microtubules. All these fibers are 
polymers built from small protein subunits held together by noncovalent bonds 
(Alberts et al. 2008).  
 
Figure 1.1: The cytoskeleton. A cell in culture has been fixed and labeled to show   
two of its major cytoskeletal systems, the microtubules (green) and the 
actin filament (red). The DNA in the nucleus is labeled in blue.(Alberts 
et al. 2008) 
Briefly, in contrast to actin filaments and microtubules, the intermediate filaments 
are not directly involved in cell movements, but they appear to play a structural role 
by providing mechanical strength to cells. Most types of intermediate filaments are 
cytoplasmic but one type, lamins, are nucleoplasmic. Intermediate filaments found in 
cytoplasm can be grouped into three classes: (1) keratin filaments in epithelial cells, 
(2) vimentin and vimentin-related filaments in connective tissue cells, muscle cells, 
and supporting cells of nervous system; (3) neurofilaments in nerve cells.  All of 
intermediate filament proteins share a central α-helical rod domain which plays a role 
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in filament assembly. The variable head and tail domains most likely determine the 
specific functions (Cooper G.M, Hausman R.E, 2004). 
The other component of the cytoskeleton, actin, is one of the most abundant protein 
and exists in both monomeric (G-actin) and polymeric forms (F-actin). 
Polymerization of actin monomers results in twisted two-stranded structure known as 
actin microfilaments. Microfilament ends are biochemically distinct, with different 
growth rates: the slow growing “minus” end and the fast growing “plus” end. The 
microfilament network is a highly complex and dynamic structure involved in a 
variety of cellular functions such as motility, maintenance of cell shape, cell 
attachment, anchorage of cell organelles and maintenance of cytoplasmic viscosity. 
To do that actin filaments are associated with a large number of actin-binding 
proteins, e.g. myosins, cofilins, formins and gelsolins (Alberts B. et al. 2003; S.R. da 
Costa et al. 2003). 
1.2 Microtubules 
Microtubules are dynamic hollow tube like structures present in the cytoskeleton of 
all eukaryotic cells. They are involved in generation of cell morphogenesis and 
organization, cell division, cell growth and intracellular organelle transport. A 
characteristic property of microtubules is their ability to undergo cycles of rapid 
growth and disassembly known as dynamic instability. For this reason, individual 
microtubules do not have a stable length, but exist in either polymerization (growth) 
or depolymerization (shrinkage) state (Poulain F.E, Sobel A, 2010; Conde C, Caceres 
A, 2009; Antal et al., 2007).  
Microtubules are composed of α- tubulin and β- tubulin monomers (450 amino acids 
each and are about 50% identical at the amino acid level). They are stacked head to 
tail at 8 nm intervals to form “protofilaments” that run lengthwise along the wall and 
usually 13 protofilaments associate to form microtubule architecture, a hollow 
cylinder about 25 nm in diameter (Fig 1.2 a) (Burns, 1991; Meurer-Grob et al., 2001; 
Watson et al., 2004). They are nucleated at speciﬁc structures termed microtubule-
organizing centers (MTOC), and γ-tubulin is localized to MTOC and functions as a 
template for the correct assembly of microtubules (Poulain F.E, Sobel A, 2010). It is 
also found in the cytoplasm as a part of a large complex called γ-tubulin ring 
complex (γ-TuRC) (Job et al., 2003). Beside γ-tubulin dependent nucleation 
mechanism, other mechanisms independent of γ-tubulin complex components exist 
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(Kuijpers M, Hoogenraad C.C, 2011). The structure of microtubule is organized in a 
polar manner and polarity is responsible for different polymerization rates at the two 
microtubule ends, the faster growing “plus” ends being capped by β subunits and the 
slower “minus” ends by α subunits (Risinger et al., 2009).  
By polymerization and depolimerization, constitution of microtubules change 
between growing and shrinking phases, a process known as dynamic instability 
(Desai and Mitchison, 1997). In other words, dynamic instability is characterized by 
the frequencies of catastrophes (transitions from polymerization to depolymerization) 
and rescues (transitions from depolymerization to polymerization) (Fig 1.2 b) (Conde 
C, Caceres A, 2009).  
 
Figure 1.2: Microtubule tructure and dynamic instability (Conde C, Caceres A, 
2009). 
Microtubule polymerization is a complex process involving a cooperative assembly 
of α β tubulin heterodimers followed by GTP hydrolysis and there is a hydrolyzable 
GTP binding site (exchangeable site) on the β- subunit and a non-hydrolyzable site 
on the α- subunit (Meurer-Grob et al.,2001). The guanoside-triphosphate (GTP)-
bound tubulins are added at the plus end of microtubules and form a GTP cap which 
stabilizes the microtubule structure and facilitates growing of microtubule by 
addition of new dimers. Addition of new dimer triggers hydrolysis of β-tubulin 
bound GTP to GDP. Thus, the majority of β-tubulin in the microtubule fiber is in the 
GDP-bound form and ‘‘capped” with GTP-bound β tubulin at the plus end (Singh et 
al., 2008). If this GTP cap is lost by means of the GTP molecule on β-tubulin is 
hydrolyzed to GDP before another GTP-bound β-tubulin is added, the protofilaments 
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spread out and results in rapid microtubule depolymerization (Risinger et al., 2008; 
Singh et al., 2008). In addition to this model of action, it has been shown that GTP-
tubulin is not only found at plus end, but there are some GTP-tubulins (GTP-islands) 
exist in the body of microtubules. So that these GTP-tubulins would be exposed upon 
depolymerization and act as a GTP cap (Dimitrov et al. 2008).  
Together with these intrinsic processes, microtubule dynamics are regulated 
extrinsically by interaction with factors that stabilize or destabilize microtubules. 
Extrinsic regulation of microtubules is mostly due to the numerous MAPs 
(microtubule-associated proteins) that bind to microtubules (de Forges H., Bouissou 
A, Perez F, 2012), microtubule destabilizing factors, microtubule severing proteins 
and microtubule-based motors of the kinesin and dynein superfamilies (Conde C, 
Caceres A, 2009).  
MAPs such as Tau, MAP2 and MAP4, promote microtubule stability by binding to 
microtubule surface (Heald and Nogales, 2002). Kinesin and dynein superfamily 
proteins convey their cargoes along the microtubule (Hirokawa, 1998). Microtubule 
stabilizing proteins, proteins that promote polymerization or depolymerization and 
microtubule severing proteins in neurons are schematically shown in Figure 1.3.  
 
Figure 1.3: Microtubule regulating proteins (Poulain F.E, Sobel A, 2010). 
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1.3 Microtubule Severing 
Beside the dynamic instability, growth and shrinkage of microtubule plus end, or 
treadmiling, which is described as loss of tubulin subunits from minus end while 
addition at the plus end, there exists another mechanism, “cut and run” model: in 
which microtubules can be broken or severed along their length into short pieces in 
cells such as the reconﬁguration of microtubules that have already been stabilized by 
factors that bind to the surface or the ends of the microtubules, is required for 
mobility of microtubules (Quarmby L, 2000; Baas P.W, Karabay A. and Qiang L, 
2005) 
Microtubules are thus essential structures whose nucleation, stabilization and 
dynamics regulate the formation and restructuring of a complex network within cells 
(Poulain F.E, Sobel A, 2010). In mitotic cells, microtubule severing on the spindles 
is thought to contribute to spindle reorganization (Ahmad and Baas, 1995). Different 
from mitotic cells, in neurons, microtubules are not used for the formation of a 
mitotic spindles, but rather they form dense parallel arrays (bundles) in axons and 
dendrites that are required for the elongation and maintenance of these neurites 
(Conde C, Caceres A, 2009; Karabay et al., 2004). Neuronal microtubules are 
nucleated at the centrosome, rapidly released by the action of the microtubule 
severing proteins, and then transported as short polymers into neurites by molecular 
motors (Yu, W., Centonze, V. E., Ahmad, F. J. & Baas, P. W, 1993; Vale, R. D, 
2003; Hirokawa, N. & Noda, Y., 2008). 
Elongation, branching, navigation, retraction of axons  are accomplished by changes 
in the configuration of microtubules (Baas and Buster, 2004). It has been shown that 
motor proteins are essential for transporting microtubules into the axon in neurons 
(Ahmad et al., 1998) and the length of the microtubule is inversely proportional to its 
movement speed, the shorter the microtubule is the more rapid is the movement 
(Dent et al., 1999).  
To cut microtubules into smaller pieces microtubule-severing enzymes are required.  
Up to now three microtubule-severing enzymes, belonging to the AAA (ATPases 
Associated with diverse cellular Activities) family of ATPases, have been identified: 
katanin, spastin and fidgetin whose functions are essential for cellular processes such 
as mitosis, cilia biogenesis, deﬂagellation, and neurogenesis (Casanova et al., 2009; 
Roll-Mecak, A. and F. J. McNally, 2010).  
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1.4 Katanin 
The ﬁrst report of biochemical microtubule severing activity came from observations 
using Xenopus oocyte extracts (Vale, 1991). After that, katanin was puriﬁed from sea 
urchin eggs and its name derived from katana, which means the samurai sword in 
Japanese (McNally and Vale, 1993). Katanin was the first microtubule severing 
protein to be identified, sequenced, and characterized (Baas P.W., Sudo H., 2010). 
Katanin is a microtubule-severing protein proposed to be involved in mitosis, 
neuronal differentiation and flagellar physiology (McNally F., 2000). Katanin is 
heterodimer composed of two subunits, p60, which is derived from KATNA1 mRNA, 
containing the AAA ATPase domain which requires ATP hydrolysis to sever 
microtubules and the non-enzymatic p80, which is encoded from KATNB1 gene, 
containing the N-terminal WD40 repeat domain, a central proline-rich domain and a 
C-terminal domain (McNally et al., 2000; Hartman et al. 1998). 
Like the motor proteins kinesin and dynein, katanin’s ATPase activity is stimulated 
by microtubules, and katanin uses ATP hydrolysis to disassemble microtubules at 
internal sites. Katanin p60 is thought to oligomerize into a hexamer and form a ring 
that wraps around the microtubule and generates the torque needed to break its lattice 
(Figure 1.4) (Poulain F.E, Sobel A, 2010). 
 
Figure 1.4: Katanin p60 oligomerization (McNally F., 2000; Poulain F.E, Sobel A, 
2010). 
As seen in Figure 1.5 (red sword handles represent ATP; blue sword handles 
represent ADP) after ATP binding, katanin oligomerization is triggered and katanin 
assemble on the wall of the microtubule. When ATP hydrolyzed and phosphate 
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released, katanin undergoes a conformational change leading to destabilization of 
tubulin dimers (Quarmby L., 2000). 
 
Figure 1.5: Microtubule severing by katanin (Quarmby L., 2000). 
Instead of having microtubule-severing properties, p80 is thought to target the p60 
subunit to the centrosome and controls the microtubule severing activity of p60 via 
dimerization with C-terminal domain of P80 (Figure 1.6) (McNally et al., 2000). In 
addition, p80 enhances the microtubule severing capacity of p60 subunit (Ahmad et 
al, 1999). WD40 domain of p80 localizes p60 to centrosomes instead of having a 
role in dimerization (Hartman et al., 1998 ). 
 
Figure 1.6: The interaction of p60 and p80 katanin (Sudo H. and Maru Y.; 2008). 
Katanin is ubiquitously expressed and it is highly detected in the nervous system 
during periods of axonal growth. It is distributed throughout cytoplasm and 
centrosomes. In neurons, a large number of non-centrosomal microtubules are 
required for growth and maintenance of neuronal processes (Ahmad et al., 1999). 
Inhibition of katanin increases microtubule length and impairs axon growth and also 
enhances accumulation of microtubules at centrosomes, demonstrating that katanin is 
essential for releasing microtubules from neuronal centrosome and microtubule 
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severing and release from the centrosome are essential for axon elongation (Karabay 
et al., 2004) However, katanin p60 overexpression also impairs axon formation (Yu 
et al., 2005). 
A study conducted on transgenic mice model of Alzheimer's disease (AD) revealed 
that katanin levels in the cortex and hippocampus of the transgenic mice was 
decreased compared to non-transgenic normal mice (Nichols et al., 2008). In the 
model for microtubule-based axonal degeneration in Alzheimer’s disease, it has been 
suggested that hyperphosphorylation of tau which is observed in AD cases causes 
destabilization of microtubules and thus, microtubules are more accessible to 
severing proteins such as katanin (Baas and Qiang, 2005).  
1.5 Spastin 
The 68 kDa microtubule-severing enzyme, spastin was originally identiﬁed with 
mutations in its gene SPG4, the defective gene in hereditary spastic paraplegia 
(HSP), cause the disease characterized by the axonal degeneration of spinal neurons 
leading to weakness and spasticity of the lower limbs (Hazan et al., 1999). It consists 
of 616 amino acid (aa) and has two major domains: a microtubule-interacting and 
endosomal trafﬁcking (MIT) domain at the N terminus and an AAA domain at the C 
terminus (Figure 1.7) (Salinas et al. 2007). 
Figure 1.7: Structural organization of spastin. 
The MIT domain is responsible for the association of spastin with microtubules 
(Takasu et al., 2005). The AAA domain consists of approximately 220 amino acids 
and is responsible for the ATPase activity of the protein (Evans et al., 2005). 
Moreover, spastin includes two functional nuclear localization signals (NLS), 
responsible for targeting to the nucleus and nuclear export signals (NES) (Beetz et 
al., 2004; Claudiani et al., 2005). 
By function of its NLS, spastin can localize into nucleus and experimentally in 
different cell types nuclear localization of spastin was detected. Distribution of 
spastin whether in cytoplasm or nucleus, is regulated through two mechanisms; the 
usage of alternative translational start sites and active nuclear export to the 
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cytoplasm. Thus, SPG4 mRNA is able to synthesize two spastin isoforms, 68 and 60 
kDa, by using two different translational sites (Claudiani et al., 2005). 
Like other members of the AAA family, spastin tends to assemble into ring-shaped 
oligomers. As katanin does, spastin can form hexamers only in the presence of ATP 
and they can bind their substrate with high afﬁnity only in this oligomeric state (Roll-
Mecak A, Vale RD, 2008).  
With X-ray crystallography and solution light and X-ray scattering coupled with 
atomic docking, the active spastin hexamer displaying the ring structure common to 
AAA ATPases, has been revealed. The hexamer has a prominent central pore and six 
radiating arms that may be used by the enzyme to dock onto the microtubule. 
Residues that are important for microtubule severing are shown in red in Figure 1.8 
(Roll-Mecak A, Vale RD, 2008). 
 
Figure 1.8: Molecular surface of the spastin hexamer. 
In cells overexpressing wild-type spastin, disrupted microtubule network was 
observed. Furthermore, in cells overexpressing spastin with mutations in the AAA 
domain the protein bound constitutively to MT and altered MT arrays (Errico et al., 
2002). By in vivo experiments, it has been shown that downregulation of spastin by 
RNA interference (RNAi) caused morphologic undergrowth, reduced synaptic area, 
and increased synaptic microtubules. Conversely, overexpression of spastin reduced 
the synaptic strength and amount of synaptic microtubules (Salinas et al. 2007). 
1.6 ELK-1 
Elk-1, a member of the Ets (E twenty-six) oncogene family of transcription factors, is 
able to contribute both activation and repression of target gene expression (Sharrocs, 
2001; Buchwalter et al, 2004). 
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The Ets family transcription factors have a highly conserved ETS DNA-binding 
domain (DBD) of ∼85 amino acids that mediate binding to a DNA target (Mo et al. 
2000; Besnard et al. 2011). The ETS domain (A domain) of Elk-1 contains a nuclear 
localization signal (NLS) as well as a nuclear export signal (NES). A short neuronal 
isoform of Elk-1, sElk-1, a protein lacking the first 54 amino acids of the Ets DNA 
binding domain (Vanhoutte et al., 2001; Buchwalter et al. 2003 ). The B box domain 
enables TCFs to interact co-operatively with SRF and promotes ternary complex 
formation (Besnard et al., 2011). The D domain is short MAP kinase docking motif 
and C domain at the C-terminal of protein is transcriptional activation domain (Yang 
et al 2002). The R domain contains lysine residues which are target for SUMO 
(Small Ubiquitin-like Modifier) modification and SUMOylation is required for 
repressive activity of Elk-1 and can also regulate intracellular localization of Elk-1 
(Figure 1.9) (Yang et al 2003). 
 
Figure 1.9: Functional domains and major post-translational modifications of the 
Elk1 protein. 
1.7 YY1 
Transcription factor YY1 (Yin Yang 1), belongs to the GLI-Kruppel class of zinc 
finger proteins, is ubiquitously expressed in different tissues including brain, heart, 
limb and immune system. YY1 is a multifunctional protein that can activate or 
repress gene expression acting on diverse number of promoters (He Y. and Casaccia-
Bonnefil P., 2008; Thomas and Seto, 1999). At its C-terminal, YY1 contains four 
C2H2-type zinc fingers, responsible for the specific DNA-binding activity with the 
consensus sequence 5’-(C/g/a)(G/t)(C/t/a)CATN(T/a)(T/g/c)-3’. Histidine-rich 
region flanked by acidic amino acids by the N-terminal region, serves as 
transcriptional activation domain. The central glycine and lysine rich region interacts 
with histone deacetylase complex (HDAC), and together with C-terminus it forms 
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the transcriptional repression domain. Another region within the central part is PHO 
homology region (amino acids between 205 and 226), which interacts with the 
homeobox proteins (Figure 1.10) (He Y. and Casaccia-Bonnefil P., 2008).  
 
Figure 1.10: Schematic diagram of human Yin Yang 1 (YY1) protein. 
YY1 mRNA was identified in numerous tissues in mouse so its expression is thought 
to be ubiquitous and it is estimated that more than 7% of all vertebrate gene 
promoters contain at least one YY1 consensus binding site. Therefore it may be 
involved in expression control of a vast array of genes (Shi et al. 1997; Ohtomo, 
2007). 
It has been shown in vitro that YY1 directs and initiates transcription when bound to 
initiator (Inr) elements. YY1 can function like TATA-binding protein (TBP),  and it 
binds to the core promoter and recruits RNA polymerase to the initiation complex. 
Experimentaly, physical interaction between YY1 and TFIIB  and the large subunit 
of RNA polymerase II was identified and it was sufficient to direct basal 
transcription of a supercoiled plasmid template in vitro (Shi, 1997). 
Three general models for both YY1 mediated activation and repression have 
proposed (Figure 1.11.a and b respectively). For activation, in the first model, it has 
been proposed that YY1 stimulates transcription by directly interacting with general 
transcription factors. In this mechanism, it is most likely that YY1 uses an activation 
domain. In the second model, it has been proposed that interacting with other 
proteins YY1 can activate a promoter, which was repressed by YY1 in the absence of 
those factors. It is likely that this regulation is achieved by anti-repression and/or the 
unmasking of an activator domain. In the third model, it has been proposed that YY1 
recruits a coactivator which modifies or interacts with other transcription factors. In 
this mechanism, chromatin modification is also likely to achieve an open or 
accessible chromatin state (Thomas, 1999). 
For repressive effect, in the first model, it has been proposed that repression is 
achieved by displacement of an activator by YY1 through overlapping DNA binding 
 12 
sites or possibly through some other mechanisms (such as bending of the DNA). In 
the second model, it has been proposed that YY1 prevents activator function by 
interfering with the function of other critical transcription factors, which may be 
activators or general transcription factors. This could also be achieved by squelching 
of coactivators. In the third model, it has been proposed that YY1 recruits a 
coactivator, which either negatively interacts with other factors or modifies them. 
This could also be achieved through chromatin modification to achieve a closed 
chromatin state (Thomas, 1999). 
 
Figure 1.11: Models of YY1 mediated activation and repression (Thomas, 1999). 
The potential function of YY1 in the developing nervous system was suggested by 
the phenotypic analysis of yy1+/− mice, indicating an early embryonic lethality 
which restained the analysis of later developmental stages caused by complete 
ablation of yy1 in mice (Donohoe et al. 1999). The role of YY1 in late neuronal 
differentiation has been suggested by the evidence that this molecule positively 
regulates the basal levels of expression of dopamine beta-hydroxylase (DBH) in 
noradrenergic neurons (which catalyzes dopamine to noradrenaline), by binding to 
specific sites in the promoter (He and Casaccia-Bonnefil, 2008). YY1 might also 
play a role in the neurological diseases such as AD. YY1 acts as an activator of the 
BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) promoter (Nowak 
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et al., 2006) in which its gene product cleaves Aβ proteolytically from amyloid 
precursor protein (APP) in neurons and astrocytes (Rossner et al., 2006). Moreover, 
mutations of the YY1 binding site in the BACE1 promoter decrease its activity, 
while YY1 over-expression increases its transcriptional activity (Nowak et al. 2006). 
1.8 Aim of the Study 
Optimal promter regions of KATNB1 and SPG4 were previously identified by our 
laboratory. According to deletion constructs, S2 construct containing the 5’ upstream 
region -921/-221 of SPG4 gene was selected as optimal promoter because of higher 
promoter activity (Figure 1.12). In the same way, F2 construct containing the region 
-892/-375 of KATNB1 gene was chosen as optimal promoter (Figure 1.13).  In this 
study, in order to understand transcriptional regulation of human KATNB1 and SPG4, 
primarily Elk-1 and YY1 binding sites on KATNB1 and SPG4 gene promoters will be 
identified. To check specificity of their binding, recombinant YY1 and Elk-1 
proteins, which contain only DNA binding regions and a 6X Histidine tag (6XHis-
tag), will be produced in E. coli and purified via His-tag. Finally, regulation of these 
promoters by YY1 transcription factor will be investigated using Dual-Luciferase 
Reporter system.  
 
Figure 1.12: Schematic representation of SPG4 gene promoter (a) and deletion 
constructs analysis (b). 
 14 
 
Figure 1.13: Schematic representation of KATNB1 gene promoter (a) and deletion 
constructs analysis (b). 
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Lab equipment 
The equipment used in the study are given in the Table 2.1: 
Table 2.1: Laboratory equipment used in the study 
Equipment Supplier Company 
Centrifuges Biolab SIGMA 6K15, Beckman Coulter 
Microfuge®18, Beckman Coulter AvantiTM J-30 I, 
IECCL10 Centrifuge,  
Thermo Electron Corporation, Labnet, Labnet 
International C1301-230V 
DNA sequencer Applied Biosciences 3100 Avant 
High pressure steam sterilizer TOMY SX-700E 
Magnetic stirrer Labworld Standard Unit 
pH Meter Mettler Toledo MP220 
Precision Weigher Precisa 620C SCS 
Weigher Precisa BJ 610 C 
UVIPhoto MW Version 99.05 for Windows 
95 & 98 
UVItec Ltd. 
UV Transilluminator Biorad UV Transilluminator 2000 
Electrophoresis equipments ThermoEC MiniCell® PrimoTM 
EC320 Electrophoretic Gel System 
Power supply EC250-90 Apparatus Corporation 
Microwave Arçelik MD582 
Ice machine Scotsman AF 10 
Vortex Heidolph, Reaxtop 
Water Baths Memmert, Elektro-mag M 96 KP 
Thermomixer Eppendorf Thermomixer Comfort 
Laminar air flow cabinets FASTER BH-EN 2003 
Incubator with CO2 Biolab SHEL LAB 
UVIPhoto MW Version 99.05 for Windows 
95 & 98 
UVItec Ltd. 
Inverted light microscope Olympus CK40 
Thermal Cycler Techne TC-3000 
SDS-PAGE gel electrophoresis system BIO-RAD MiniProtean 
Power supply  Thermo Electron Corporation EC250-90 
Shaker Forma Orbital Shaker,  
Thermo Electron Corporation 
Freezers UĞUR (-20oC), UĞUR (+4 oC), New Brunswick 
Scientific (-80 oC) 
UV-Visible Spectrophotometers uv-1700 PharmaSpec Shimadzu, Thermo scientific 
NanoDrop 2000 
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Table 2.1 (contd.) : Laboratory equipment used in the study 
Microplate Spectrophotometer BIORAD Benchmark Plus 
Pure water system TKA Wasseraufbereitungssysteme 
Mini Blot Module Thermo Electron Corporation EC140 
Syringe filters 0.22µm, TPP 
Vacuum filtration- system 150ml, TPP 
Pipettes 2.5µl, 10µl, 100µl, 200µl,  Eppendorf 1000µl,   
Finnpipette Thermo 
Electronic pipette Finnpipette Thermo  
Microfuge tubes  1.5ml, 2ml, Axygen 
Centrifuge tubes  15ml, 50ml Avant Plus 
Tissue culture test plates 6 well, 12 well, 96 well, TPP 
Tissue culture flasks 25 cm2, 75cm2 TPP 
Cell Scraper 30cm, TPP 
Hemacytometer Fisher Scientific 
Injectors 2ml, inject, 1ml, tuberculin 
Serological pipette TPP 
Nitrocellulose membrane Roche 
3MM Whatman Filter Paper Whatman 
2.1.2 Chemicals and enzymes 
Chemicals and enzymes used in the study are shown in the Table 2.2: 
Table 2.2 Chemicals and enzymes 
Material Supplier Company 
BamHI restriction enzyme 
XhoI restriction enzyme 
KpnI restriction enzyme 
EcoRI restriction enzyme 
SalI restriction enzyme 
MassRuler™ DNA Ladder (Mix, 80bp-10Kb) 
Mass Ruler Low Range DNA Ladder (80-1031 bp) 
10 mM dNTP mix  
2 mM dNTP mix 
10 X Pfu  DNA polymerase Buffer (with MgCl2) 
10X Tango Y buffer 
25 Mm MgCl2  
10X Y+ Tango buffer 
6X Loading dye 
Fermentas 
T4 DNA Ligase Buffer  
T4 Ligase  
Roche 
SeeBlue Plus2 Prestained Protein Ladder Invitrogen 
Primer T7 promoter 
Primer T7 terminator 
Integrated DNA Technologies 
IPTG 
TEMED 
AppliChem 
NaH2PO4.2H2O 
KH2PO4 
K2HPO4  
NaAc 
J.T. Baker 
Tryptone Lab M TM 
Isopopanol 
Glycerol 
PEG 8000 
Coomassie Brilliant Blue 
 
 
Fluka 
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Table 2.2 (contd.): Chemicals and enzymes 
Ampicillin 
Kanamycin 
Albumine, bovine (BSA) 
N,N’- Dimethyl- bis- Acrylamide 
4-Nitrophenyl phosphate di (tris) salt 
 
 
 
 
Sigma 
Anti-His penta monoclonal Mouse antibody 
50% Ni-NTA agarose suspension 
Qiagen 
Tris Base 
Acrylamide 
 
BDH Laboratory 
DMSO 
Absolute methanol  
Absolute ethanol 
 
Riedel- de Haёn 
Boric acid 
APS 
CaCl2.2H2O 
EDTA 
SDS 
Glucose 
Ethidium bromide 
Yeast Extract 
Agar  
KCl 
Imidazole 
PEG 4000 
DTT  
HCl 
Bromophenol blue 
 
 
 
 
 
Merck 
MgCl2.6H2O  
NaCl 
CARLO ERBA 
Skimmed milk powder OXOID 
DMEM- High Glucose- Liquid Media (SH30243) HyClone 
FBS Biochrom 
2.1.3 Commercial kits 
Commercial kits used in this study are given in the Table 2.3: 
Table 2.3: Commercial kits 
Kit Supplier Company 
QIAquick PCR purification kit Qiagen, 28104 
QiaPrep Spin Miniprep Kit Qiagen, 27106 
Big Dye Terminator v 3.1 Cycle Sequencing Kit Applied Biosystems 
EndoFree Plasmid Maxi Kit Qiagen 12362 
SDS Gel Preparation Kit Fluka 08091 
QIAquick Gel Extraction Kit Qiagen, 28706 
Dual-Luciferase Reporter Assay System Promega, E1910 
Transfast Transfection Reagent Promega, E2431 
LightShift Chemiluminescent EMSA Kit  Thermo Scientific 20148 
Chemiluminescent Nucleic Acid Detection 
Module Kit  
Thermo Scientific 89880 
Biotin 3’ End DNA Labeling Kit Thermo Scientific 8918 
QuikChange II Site-Directed Mutagenesis Kit Agilent Technologies 200523 
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2.1.4 Buffers and solutions 
2.1.4.1 TBE buffer (10X)  
10X TBE buffer was used in agarose gel electrophoresis to prepare the agarose gel 
that DNA was loaded on and as the tank buffer. 10X TBE buffer was used by 
diluting to 0.5X TBE buffer with dH2O. Preparation of 10x TBE is shown in Table 
2.4 
Table 2.4: Preparation of 10X TBE buffer 
Content Concentration Amount 
Tris Base 890 mM 108 g 
Boric Acid 890 mM 55 g 
EDTA 
H2O 
20 mM 5.84 g 
1 L 
2.1.4.2 TAE Buffer (50X) 
50X TAE buffer was used in agarose gel electrophoresis to prepare the agarose gel 
that DNA was loaded on and as the tank buffer. 50X TAE buffer was used by 
diluting to 1X TAE buffer with dH2O. Preparation of 50x TAE is shown in Table 
2.5. 
Table 2.5: Preparation of 10X TBE buffer 
Content Concentration Amount 
Tris Base 2 M 242 g 
Glacial Acetic Acid  57.1 mL 
EDTA 
H2O 
50 mM 14,6 g 
1 L 
2.1.4.3 Protein purification buffers 
Protein purification buffers were used for purifying proteins from bacterial pellet by 
metal affinity chromatography. Buffer types and their preparations are given below: 
Lysis buffer: 78 miligram (mg) NaH2PO4.2H2O (50mM), 175.4 mg NaCl (300mM) 
and 6.8 mg imidazole (10 mM) were dissolved in 10 ml distilled water (dH2O) and 
pH was adjusted to 8.0 using NaOH. 
Wash buffer: 78 mg NaH2PO4.2H2O (50 mM), 175.4 mg NaCl (300 mM) and 13.6 
mg (20mM) were dissolved in 10 ml distilled water (dH2O) and pH was adjusted to 
8.0 using NaOH. 
Elution buffer: 39 mg NaH2PO4.2H2O (50 mM), 87.7 mg NaCl (300 mM) and 
2.72 gram (g) (4 M) were dissolved in 5 ml distilled water (dH2O) and pH was 
adjusted to 8.0 using NaOH. 
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2.1.4.4 Buffers and solutions for SDS-PAGE analysis  
2X sample buffer: 2X sample buffer was used to denature protein samples which 
were loaded on SDS- polyacrylamide gel. Preparation of 2X sample buffer is shown 
in Table 2.6. 
Table 2.6: Preparation of 2X sample buffer 
Content Concentration Amount 
Tris- HCl pH:6.8 0.125 M 2.5 ml (of 0.5 M) 
SDS 4 % 4 ml (of 10%) 
Glycerol 20 % 2 ml (of 100 %) 
Bromophenol blue 0.05 % 5 mg  
DTT 0.15 M 231 mg 
dH2O  up to 10 ml 
Tris-Tricine anode buffer (pH: 8.9): Tris-Tricine anode buffer was used to reduce 
pH of the solution changes. Preparation of Tris-Tricine anode buffer is shown Table 
2.7. 
Table 2.7: Preparation of Tris-Tricine anode buffer 
Content Concentration Amount 
Tris Base 0.2 M 24,22 g 
dH2O  up to 1 liter 
Tris-Tricine cathode buffer (pH: 8.25): Tris-Tricine anode buffer was used to 
reduce pH of the solution changes. Preparation of Tris-Tricine cathode buffer is 
shown Table 2.8. 
Table 2.8: Preparation of Tris-Tricine cathode buffer 
Content Concentration Amount 
Tris Base 
Tricine 
SDS 
0.1 M 
0.1 M 
0.1 % 
12,11 g 
17,92 g 
1 g 
dH2O  up to 1 liter 
Gel Buffer (pH: 8.45): Preparation of gel buffer is shown Table 2.9. 
Table 2.9: Preparation of gel buffer 
Content Concentration Amount 
Tris Base 
SDS 
3 M 
0.3 % 
182 g 
1,5 g 
dH2O  up to 500 ml 
Stacking Acrylamide: Preparation of gel buffer is shown Table 2.10. 
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Table 2.10 : Preparation of stacking acrylamide 
Content Concentration Amount 
Acrylamide 
Bis-acrylamide 
48 % 
1.5 % 
48 g 
1.5 g 
dH2O  up to 100 ml 
Seperating Acrylamide: Preparation of gel buffer is shown Table 2.11. 
Table 2.11 : Preparation of seperating acrylamide 
Content Concentration Amount 
Acrylamide 
Bis-acrylamide 
46.5 % 
1.5 % 
46.5 g 
1.5 g 
dH2O  up to 100 ml 
Coomassie Brilliant Blue (CBB) stain solution: CBB stain solution was used to 
visualize separated protein bands on SDS polyacrylamide gel. Preparation of CBB 
stain solution is shown below: 
Table 2.12: Preparation of CBB stain solution 
Content Concentration Volume 
CBB R-250 
Methanol 
Acetic acid 
dH2O 
0.1 % 
45 % 
10 % 
45% 
0.5 g 
450 ml 
100 ml 
450 ml 
Destain solution: Destain solution was used to visualize protein bands clearly by 
removing the background on SDS polyacrylamide gel. Preparations of CBB destain 
solution is shown below: 
Table 2.13: Preparation of destain solution 
Content Concentration Volume 
Methanol 
Acetic acid 
dH2O 
45 % 
10 % 
45 % 
450 ml 
100 ml 
450 ml 
2.1.5 Bacterial strains 
Escherichia coli (E.coli) DH5α strain [F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, 
deoR, recA1, endA1, hsdR17(rk
-
, mk
+
), phoA, supE44, λ-, thi-1, gyrA96, relA1], 
Invitrogen. 
Escherichia coli strain BL21 (DE3)pLysS F– dcm ompT hsdS(rB– mB–) gal (DE3)[pLysS 
Camr], Novagen. 
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2.1.6 Bacterial culture media 
LB medium was prepared by dissolving 10 g tryptone, 5 g yeast extract, and 10 g NaCl 
in 1 liter distilled water. The media was sterilized by autoclaving at 121
o
C for 10 
minutes (min). After sterilization, antibiotic was added to the LB medium according 
to the concentration mentioned in Table 2.12 in order to make selection media. 
LB- agar plate was prepared by adding 15 g/L of agar to LB medium and sterilized 
autoclaving as describe above. 
SOC medium was used to cultivate E. coli cells for 1 hour after heat shock during 
transformation. It was prepared by dissolving 2 g tryptone, 5 g yeast extract, 0.058 g 
NaCl, 0.0186 g KCl, 0.095 g MgCl2, 0.23 MgSO4 and 0.36 g glucose in 100 ml 
distilled water and sterilized at 121 °C with autoclaving for 10 min. 
Table 2.14: Stock and working solutions of antibiotics 
Antibiotic Stock Solution 
Concentration 
Working Solution 
Concentration 
Kanamycin 30 mg/ml in distilled water 30 μg/ml 
Ampicilin 50mg/ml in distilled water 50 μg/ml 
2.1.7 Expression vectors 
2.1.7.1 pET-30a vector 
The pET-30a (+) vector carries an N-terminal His•Tag®/thrombin/S•Tag™/ 
enterokinase configuration plus an optional C- terminal His•Tag sequence. The 
circular map (Fig. 2.1) and the cloning/expression region (Fig. 2.2) are shown below. 
The vector is 5422 bp long. 
 
Figure 2.1: Vector map of pET30a (Url-3). 
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Figure 2.2: Multiple cloning site of pET30a (Url-4).                           
2.1.7.2 pCMV6 vector 
The pCMV6 mammalian expression vector consists of the promoter-enhancer region 
of the major immediate early gene of the human cytomegalovirus, a synthetic copy 
of the translational enhancer from the alfalfa mosaic virus 4 RNA, a synthetic 
polylinker sequence containing unique cleavage sites for 13 restriction enzymes, the 
transcription termination and polyadenylation region of the human growth hormone 
gene, and the SV40 virus DNA replication origin and early region enhancer from 
plasmid pcD-X. After introduction into mammalian cells, the vector is designed such 
that transcription originating from the strong cytomegalovirus promoter will traverse 
the translational enhancer and polylinker sequences and terminate in the human 
growth hormone gene region (Andersson,S. et al, 1989). The circular map (Fig. 2.4) 
is shown below. The vector is 4665 bp long. 
 
Figure 2.3 Vector map of pCMV6 (Url-2) 
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2.1.8 Cell culture media 
SH-SY5Y Culture Medium  
To prepare SH-SY5Y culture medium, DMEM low glucose was supplemented with 
10% FBS, 2 mM L-Glutamine and 1X Penicilin/Streptomycin and then filter 
sterilized with 0,2 µm filter.  
SH-SY5Y Freezing Medium  
To prepare SH-SY5Y freezing medium, SH-SH5Y culture medium was 
supplemented with 5% DMSO and then filter sterilized with 0,2 µm filter.  
2.1.9 Cell Lines 
In this study, SH-SY5Y Human metastatic neuroblastoma cell line was was used. 
Those cells are clonal subline of the neuroepithelioma cell line SK-N-SH that had 
been established in 1970 from the bone marrow biopsy of a 4-year-old girl with 
metastatic neuroblastoma. 
2.2 Methods 
2.2.1 Cloning studies 
2.2.1.1 Primer design 
In order to clone desired nucleotide sequence of target DNA, primers with 
appropriate flanking restriction sites were designed to allow ligation into appropriate 
vectors. During primer design, melting temperatures of primers were selected as 
close as possible to each other to apply the optimum annealing temperature. GC 
content of primers was selected as much as ideal and hairpin and self-dimer 
formation were checked by IDT Scitools oligo analyzer (Url-1). To introduce 
mutation to convert YY1 residue lysine 288 to arginine, mutation primers were 
designed using Quick Change Primer Design tool (Url-2).  
Synthesized primers with their properties are given below: 
Table 2.15: YY1 and Elk-1 constructs’ primers 
Primer Sequence Length Tm  GC 
content 
Elk1-db_F AAGGATCCATGGACCCATCTGTGACGCT 28 64.7oC 53.6 % 
Elk1-db_R AACTCGAGAGTGGAGCACCCTGCGA 25 65.5oC 60.0 % 
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Table 2.15 (contd): YY1 and Elk-1 constructs’ primers 
YY1-
woa_F 
ATAAGGTACCGGCAAGAGCGGCGGCG 26 68.3 oC 65.4 % 
YY1-
wor1_F 
CCGAATTCATGGCCTCGGGCGACACC 26 67.2 oC 65.4 % 
YY1-
wor1_R 
AAAGGTACCGGCCGCCGCCACGGTGA 26 71.2 oC 69.2 % 
YY1-
wor2_F 
AAGGTACCAAGAAGTGGGAGCAGA 24 59.8 oC 50.0 % 
YY1-
wor2_R 
AAGGATCCTCACTGGTTGTTTTTGGC 26 59.7 oC 46.2 % 
YY1-db_F CAGAATTCACAATAGCTTGCCCTCATAAAGG 31 59.3 oC 41.9 % 
YY1-db_R AAGTCGACTCACTGGTTGTTTTTGGCCTTA 30 61.7 oC 43.3 % 
Table 2.16: YY1-K288R mutation primers 
Primer Sequence Leng
th 
Tm  GC 
content 
YY1-K288R-F gaatttgctagaatgaagccaagaaaaattagagaagatgatgctcc
a 
48 79.2
o
C 35.4 % 
YY1-K288R-R tggagcatcatcttctctaatttttcttggcttcattctagcaaattc 48 79.2oC 35.4 % 
2.2.1.2 PCR 
In order to amplify desired DNA products, WT Elk1 or YY1 containing pCMV6 
vectors were used. Following PCR reaction and PCR program were applied. 
Table 2.17: PCR reaction set up for cloning YY1 and Elk1 constructs 
Content Volume 
Template vector 50 – 100 ng 
Forward primer (25 µM) 0.5 µl 
Reverse primer (25 µM) 0.5 µl 
10X DreamTaq  Buffer 2.5 µl 
dNTP (2mM) 2.5 µl 
DreamTaq DNA polymerase (2.5u/µl) 0.5 µl 
MQdH2O Up tp 25 µl 
Total reaction: 25 µl 
  
Table 2.18: PCR program for amplification 
 Temperature Time 
Initial denaturation 95 oC 2 min 
Denaturation 95 oC 30 seconds (sec) 
Annealing Depends on primer 
temperature 
30 sec 
Extension 72 oC 30 sec to 1 min (depends 
on amplicon length) 
Final extension 72 oC 5 min 
2.2.1.3 PCR for Site Directed Mutagenesis 
In order to introduce a mutation to the desired site in YY1 gene, pCMV6 vector 
containing WT YY1 was used. Following PCR reaction and PCR program were 
applied. 
35 cycles 
each 
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Table 2.19: PCR reaction set up for cloning YY1 and Elk1 constructs 
Content Volume 
Template vector 50  ng 
Forward primer (25 µM) 0.5 µl 
Reverse primer (25 µM) 0.5 µl 
10X Reaction  Buffer 2.5 µl 
dNTP mix 0.5 µl 
PfuUltra HF DNA polymerase (2.5u/µl) 0.5 µl 
MQdH2O Up tp 25 µl 
Total reaction: 25 µl 
  
Table 2.20 : PCR program for amplification 
 Temperature Time 
Initial denaturation 95 oC 30 sec 
Denaturation 95 oC 30 sec 
Annealing 55 oC 1 min 
Extension 68oC 1 minute/kb of plasmid 
length 
2.2.1.4 Agarose gel electrophoresis 
To separate DNA fragments by their sizes agarose gel electrophoresis is used. In this 
project, 1 % or 1,5 % agarose gels were used to estimate the size of DNA molecules 
following PCR reaction and restriction enzyme digestion. 
To prepare 1 % agarose gel 
• 1g agarose was dissolved in 50 ml (small gel) 0,5X TBE (Tris/Borate/EDTA)  or 
1X TAE (Tris/Acetic Acid/EDTA) buffer. 
• The agarose was solubilized by heating until the agarose was completely 
dissolved.  
• Gel was cooled to ≤ 45ºC and ethidium bromide was added to a final 
concentration of 0.5 µg/ ml and mixed through gentle swirling. 
• The agarose gel was then poured into a horizontal gel tray, and a comb for 
forming the sample slots was placed into the gel. 
• Approximately 15 min later the gel was solidified and then placed into an 
electrophoresis tank, where the gel was covered with 0,5X TBE buffer. 
The DNA was mixed with 6X loading dye in the proportion of 5:1 and the sample 
was placed into a well on the agarose gel. For the fragment size control, a 
MassRuler™ DNA Ladder, Mix (80bp-10kb) was used. Electrophoretic separation 
was achieved by constant current at 120 mV for 30 min. 
16 cycles 
each 
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DNA within agarose gels were visualized under UV light The size of the DNA was 
determined by comparing their mobility with the fragments of the DNA ladder. 
2.2.1.5 DNA cleanup 
In order to purify double-stranded PCR products (100 bp – 10 kb) and also to clean 
up the restriction reaction products for further processes, QIAquick PCR purification 
kit was used according to instructor’s manual. 
2.2.1.6 Determination of DNA concentration  
Recovery, purity and concentration of nucleic acids were determined 
spectrophotometrically with NanoDrop 2000. The ratio of absorptions at 260 nm vs 
280 nm is commonly used to assess the purity of DNA with respect to protein 
contamination, since protein (in particular, the aromatic amino acids) tends to absorb 
at 280 nm. According to the literature, the ratio of absorbance (A260/A280) of a pure 
DNA solution is between 1.8 and 2.0. As protein contamination increases, the ratio 
decreases.     
2.2.1.7 DNA cleavage by restriction endonucleases 
Restriction enzymes used in this study were BamHI, XhoI, KpnI, EcoRI and SalI of 
which restriction sites were present in both expression vector and flanking region of 
PCR product (insert), but not found inside the insert. Plasmid vector was cut at 37
o
C 
for 3 - 4 hours and insert was cut overnight at 37
o
C with 1X Tango Y buffer 
(supplied by the manufacturer). Restriction reaction was completed by inactivation at 
80
o
C for 20 min and then DNA was purified from restriction mixture by using 
QIAquick PCR purification kit. Restriction reaction mixtures are given in table 2.21. 
Table 2.21: Restriction reaction mixture 
Content Amount Volume 
Plasmid Vector (pET-30a) 
Enzyme 1 
Enzyme 2 
10X Tango/Y Buffer 
~3 µg 
10 - 20 units 
10 - 20 units 
1X 
Depends on concentration 
1 - 2 µl 
1 - 2 µl 
1.5 µl 
Total Reaction Volume  15 µl 
Plasmid Vector (pET-30a) 
Enzyme 1 
Enzyme 2 
10X Tango/Y Buffer 
~3 µg 
10 - 20 units 
10 - 20 units 
1X 
Depends on concentration 
1 - 2 µl 
1 - 2 µl 
1.5 µl 
Total Reaction Volume  15 µl 
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2.2.1.8 Ligation  
The insert (YY1, YY1-db, YY1-woR, YY1-woA, YY1K288R or Elk1-db) was 
ligated to restricted expression vector (pET-30a or pCMV6) by T4 ligase. The ration 
of vector and DNA fragment 1:3 (vector versus insert DNA) was used in ligation 
processes. 
Ligation was performed overnight at room temperature. After overnight incubation, 
T4 DNA ligase was inactivated by incubation for 10 min at 65°C. Ligation reaction 
mixture is shown in Table 2.22 was used. 
Table 2.22 Ligation reaction mixtures 
Content Amount Volume 
Plasmid vector  30 ng Depends on concentration 
Insert DNA  90 ng Depends on concentration 
10 X T4 Buffer 1X 1,5 µl 
T4 Ligase 1 unit 1 µl 
MQdH2O  up to15  µl 
Total Reaction Volume  15 µl 
2.2.1.9 Competent cell preparation- CaCl2 method 
Competent cells were prepared according to the following protocol: 
• E.coli – DH5α or E.coli-BL21 cells were taken from a glycerol stock culture by 
scraping with a tip and it was directly put in a falcon containing 5 ml LB medium 
and incubated overnight at 37°C in an orbital shaker. 
• The following day, 100 ml LB medium was inoculated with 5 ml of overnight 
culture solution and was incubated at 37°C in an orbital shaker. Cell density was 
measured several times by a spectrophotometer at OD600. When the OD600 
reached to 0.6 the bacteria were transferred to 50 ml prechilled sterile 
ultracentrifuge tubes and incubated on ice for 10 min.  
• The cells were spun down at 1600 x g for 7 min at 4ºC, the supernatant was 
discarded. 
• Each bacterial pellet was resuspended in 10 ml ice-cold CaCl2 and centrifuged for 
5 min at 1600 x g at 4ºC, the supernatant was discarded. 
• Each bacterial pellet was resuspended in 10 ml ice-cold CaCl2 and they were 
incubated on ice for 30 min. 
• Centrifugation was performed again at 1600 x g for 5 min at 4ºC 
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• Each pellet was resuspended completely in 2 ml of CaCl2. 
• The competent cells were distributed into prechilled sterile microfuge tubes each 
contains 50 μl and they were stored at – 80ºC. 
For 50 ml CaCl2 solution following contents with mentioned concentrations and 
amounts in Table 2.23 were used. 
Table 2.23: CaCl2 solution preparation 
Content Concentration Amount 
CaCl2.2H2O 
PIPES 
Glycerol 
dH2O 
60 mM 
10 mM 
15 % 
X 
0.442 g 
0.15 g 
7.5 ml (from 100 %) 
up to 50 ml 
2.2.1.10 Transformation of competent cells 
To introduce the DNA into the host following protocol was applied;  
• The competent cells were taken from –80oC and were thawed on ice. 2 μl of 
purified plasmid DNA or 15 μl of ligation mixture was added to 20 μl of 
competent cells and the eppendorf tube containing the cells was incubated on ice 
for 30 min. 
• Then, heat shock was done by putting the cells in water bath at 42o C for 45 sec 
and they were then immediately incubated on ice for 2 min.  
• 80 μl of SOC medium was added to competent cells and the eppendorf tube was 
vigorously shaked at 37
o
 C for 1 hour.  
• The cells were then spread onto LB plate containing the appropriate antibiotic 
(kanamycin). The plates were incubated at 37
o
 C overnight. 
2.2.1.11 Colony PCR 
After transformation of ligated plasmids, colony PCR was performed to be sure of 
selecting right colonies which were carrying inserts. 
• 10 µl of sterile MQdH2O was put into PCR tubes for each colony that was taken 
from the replica plate by sterile tips and incubated at room temperature for 5 min 
to drop into water. 
• Tubes containing water and a piece of colony were incubated at 85oC for 5 min to 
blow up cells and release plasmids. 
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• Then, PCR mixture mentioned in table 2.24 was added into tubes. The PCR 
program was the same as given before in Table 2.18. 
Table 2.24: Colony PCR reaction 
  
 
 
 
 
 
2.2.1.12 Small scale plasmid DNA preparation 
After identification of the right colonies containing the inserts by colony PCR, these 
colonies were taken into 5 ml LB medium containing 5 μl suitable antibiotic 
(kanamycin or ampicilin) in order to make selection media. Then, they were 
incubated overnight with vigorous shaking (200rpm) at 37
 o
C.  
Plasmid preparation was performed using QIAGEN, QIAPrep Spin Miniprep Kit for 
small-scale (mini) preparations, following instructions of the manufacturer. 
2.2.1.13 DNA sequencing 
In order to confirm if correct amplicon was inserted into vector, sequencing was 
performed.  
PCR for sequencing:. 
The plasmids with inserts were verified by DNA sequencing using Big Dye 
Terminator v 3.1 Cycle Sequencing Kit (Applied Biosystems). The sequence reaction 
was prepared according to Table 2.25 
Table 2.25 : Sequence PCR set up 
Content Amount Volume 
Big dye reaction mix  
5X sequence mixture  
X 
X 
2 µl 
2 µl 
Template DNA 150 ng 1 µl 
T7 Primer (promoter/ terminator) 25 µM 0,5 µl 
dH2O  X up to10 µl 
The sequence reactions were performed using a thermal cycler with the following 
program mentioned in Table 2.26.  
Content Volume 
Template + water 10 µl 
Forward  primer (25 
µM) 
0.5 µl 
Reverse primer (25 
µM) 
0.5 µl 
10X Taq Buffer 2.5 µl 
dNTP mix (2 mM) 2.5 µl 
Taq  polymerase 0.3 µl 
MQdH2O 8.7 µl 
Total reaction: 25 µl 
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Table 2.26 : Sequence PCR program 
 Temperature Time 
Initial denaturation 95 oC 5 min 
Denaturation 95 oC 10 sec 
Annealing 50 oC/55 oC 10 sec 
Extension 60 oC 4 min 
Final extension 60 oC 8 min 
PCR cleanup for sequencing: The protocol is given below: 
• 10 μl PCR product was taken in to microfuge tube then 2μl of 3M NaAc and 50 
μl ice-cold 95% ethanol were added to the tube. 
• Tubes were incubated on ice for 30 min. 
• Mixture was centrifuged at 14000 rpm for 20 min Supernatant was discarded, and 
pellet was resuspended in ice-cold 70 % ethanol. The mixture was vortexed 
vigorously for ~30 sec.  
• Tubes were centrifuged at 14000 rpm for 20 min. Supernatant was discarded. 
• Tubes were incubated at 95°C for 5 min with caps open (in order to evaporate 
ethanol). 
• 20 μl of formamide was added to DNA pellet and the mixture was vortexed 
vigorously for ~30 sec.  
• Tubes were again incubated at 95 °C for 5 min with caps closed. 
• Tubes were immediately put on ice and kept at 4 °C until analysis. 
2.2.1.14. Alignment of sequence results 
Nucleotide alignments were made with EMBOSS Pairwise Alignment Algorithms 
Tool and NCBI BLAST tool (available online respectively at these web addresses: 
www.ebi.ac.uk/Tools/emboss/align/index.html and www.ncbi.nlm.gov/BLAST) in 
order to compare the sequencing results with originally expected one. 
2.2.2 Protein expression studies 
In this study, cDNA covering only DNA binding domain of Elk-1 and YY1 were 
cloned separately into pET-30a expression vector that is under the control of T7 
promoter and BL21(DE3)pLysS cell strain was used as  host in order to express 
desired protein.  
40 cycles 
each 
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2.2.2.1 Protein expression induction 
pET-30a vectors with cloned YY1-db and Elk-1-db were transformed into 
BL21(DE3)pLysS competent cells,  they were spread on LB agar plate containing 
kanamycin and incubated overnight at 37
o
C. The next day, a single colony from each 
plate was taken into 5 ml LB media (with kanamycin) in falcon tube and left for 
overnight growth at vigorous shaking at 37
o
C. Next day, 2 ml of overnight culture 
was diluted with LB media and placed into 50 ml LB media. Culture was incubated 
with shaking at 37°C until the OD600 reaches a value between 0.6 and 0.8. After cells 
were induced with 0.5 mM IPTG, they were grown for 10 hours with shaking at 
37°C. While cells were growing, samples were taken with two hours intervals for 
further analysis.  
2.2.2.2 Total cell protein analysis 
• At various times (0-8 hours) following induction, 1 ml cell culture for induction 
analysis was collected by centrifugation for 5 min at 14000x g in a microfuge. 
• Supernatant was discarded. Pellet was mixed with 50 µl 2X SDS sample buffer 
for SDS-PAGE analysis explained below 
2.2.2.3 SDS-polyacrylamide gel electrophoresis of proteins (SDS-PAGE) 
Tricine/polyacrylamide gel with 15 % acrylamide concentration which is suitable for 
separating 10-43 kDa proteins was prepared since molecular weight of expressed 
Elk1-db and YY1-db  was expected to be around 20-25 kDa. Preparations of each 
mini gels were mentioned below: 
Table 2.27 : 15 % separating gel solution (6ml) 
Contents Volume 
Seperating acrylamide 2 ml 
Gel Buffer 2 ml 
50 % Glycerol 2 ml 
10 % APS 75 µl 
TEMED 7.5 µl 
dH20 - 
Table 2.28 : 5 % stacking gel solution (3 ml) 
Contents Volume 
Stacking acrylamide 0.25 ml 
Gel Buffer 
dH20 
0.75 ml 
2 ml 
10 % APS 20 µl 
TEMED 2 µl 
 32 
The separating gel solution was applied into the gel cassette up to ± 6.5 cm, and, the 
last ± 2.5 cm of the cassette was filled with isopropanol, immediately. After the gel 
was polymerized for at least 3 min, the isopropanol was carefully removed by filter 
papers. The stacking gel solution was directly poured into the gel cassette, and the 
gel comb was placed to form the slots. The stacking gel was polymerized for at least 
1 h.  
The samples, which were denaturated for 5 min at 95ºC, were loaded on the SDS 
PAGE gel. As molecular weight marker, 5µl SeeBlue Plus2 Prestained Protein 
Ladder (Invitrogen) was loaded on the gel. 
Electrophoresis was carried out in anode and cathode buffers at constant 25mA.  
After electrophoresis, SDS-PAGE was stained in CBB stain solution. To reduce the 
time gel heated in a microwave oven for ~15 sec then placed  on a shaker and then, it 
was destained in destain solution as staining protocol.  
2.2.2.4 Metal affinity purification of 6xHis tagged YY1-db and Elk1-db protein 
Purification protocol of recombinant proteins: 
• 500 ml of IPTG induced bacterial culture was grown for 8 hours and centrifuged 
for 5 min at 14000 x g. 
• The supernatant was discarded and the pellet was frozen overnight at -80oC. 
• Next day, it was thawed on ice, resuspended in 5 ml lysis buffer (see section 
      2.1.4.2) and centrifuged for 10 min at 14000 x g. 
• 15 µl sample of lysate was taken for further SDS-PAGE analysis. 
• 500 µl of 50% Ni-NTA agarose was added to lysates and the mixture was gently 
mixed for an hour in eppendorf tubes at +4
o
C. 
• Then it was centrifuged at 4000 xg for 30 sec to separate resin and supernatant. 
The supernatant (which is also called flow-through, since it passes through the 
resin) was transferred to fresh tubes for SDS-PAGE analysis. 
• The resin was washed twice with 2.5 ml of wash buffer (see section 2.1.3 
“Buffers”). It was centrifuged at 4000 xg for 30 sec after each wash step and the 
supernatant was taken for SDS-PAGE analysis. 
• Finally, the protein was eluted 4 times with 300 µl elution buffer (see section 
2.1.3 “Buffers”). Centrifugation at 4000 xg for 30 sec was done after each elution 
step and the supernatant. 
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2.2.2.5 Protein concentration determination 
Concentration of the purified proteins was determined by Qubit® 2.0 Fluorometer 
according to manufacturer’s instructions.  
2.2.3 Cell culture studies 
2.2.3.1 Transferring cells from -80
o
C to culture flasks: Cells which had been 
stored in -80
o
C were thawed in 37
o
C water bath and taken in to 10 ml DMEM 
medium for centrifugation for 5 min at 900 rpm. Cell pellet was dissolved with 
DMEM medium and transferred to the culture flasks. 
2.2.3.2 Cell counting: Cell pellet was suspended with 10 ml DMEM. Then 10 µl 
suspension was taken and put onto the hemacytometer, cells were counted as the 
number of cells per 25 square (1mm
2
). The formula of cell number calculation is 
given below: 
10
4
 (constant number) X Amount of Counted Cell = Cell Number per ml  
Total cell number= Cell Number per ml X Total Volume of Cells (10ml)         
2.2.3.3 Cell passage: Cells in the flasks or dishes were maintained in growth 
medium. Growth medium was removed and 5 ml PBS was added. Cells stuck on the 
culture dish were lifted by trypsinization. Then cells were resuspended in growing 
medium and put into the centrifuge tubes and spun at 900 rpm. After the 
centrifugation, supernatant was discarded and pellet was resuspended with growing 
medium.  
2.2.3.4 Cell freezing: As indicated in cell passage section, after resuspending cells, 
1x10
6
 cell/ml cells were transferred to freezing tubes with growth medium containing 
5-10 % DMSO for furhter applications. 
2.2.4 Electrophoretic Mobility Shift Assay (EMSA) 
2.2.4.1 Oligo probe Biotinylation and Hybridization 
Oligo probes were labeled separately by using Biotin 3’ End DNA Labeling Kit that 
uses terminal deoxynucleotidyl transferase to incorporate 1–3 biotinylated 
ribonucleotides on to the 3’ end of DNA strands. Labeled forward and reverse oligos 
were then annealed at 1:1 ratio in 10 mM Tris, 1 mM EDTA by heating to 95 
o
C for 
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5 min, slow cooling by 2 
o
C/min to their annealing temperature, annealing for 30 min 
and cooling to 4 
o
C by 2 
o
C/min (cycle number depends on Tm of the oligos). 
Table 2.29: Oligo probes for EMSA 
Oligo name  Sequence 
Sp-Elk1-WT-1 5’-TACGAAGGCTTCCTGGCAGGAGCTC-3’ 
Sp-Elk1-Mut-1 
Sp-Elk1-WT-2 
Sp-Elk1-Mut-2 
Sp-YY1-WT 
Sp-YY1-Mut 
p80-Elk1-WT 
p80-Elk1-Mut 
p80-YY1-WT-1 
p80-YY1-Mut-1 
p80-YY1-WT-2 
p80-YY1-Mut-2 
5’-TACGAAGGAAAAATGGCAGGAGCTC-3’ 
5’-CGGAGAGGACAGCGACAGGAAGGGAGG-3’ 
5’-CGGAGAGGACAGCGACATTTTTGGAGG-3’ 
5’-CAGATTGATATCCATTGCTTCTGAG-3’ 
5’-CAGATTGATATTTGCTGCTTCTGAG-3’ 
5’-GAACGTTCCTTCCTCTTGATTAGTC-3’ 
5’-GAACGTTCTCCTTCTCCGATTAGTC-3’ 
5’-AAGCCATTGGCGCAGCCGCCATTGG-3’ 
5’-AAGTTGCTGGCGCAGCCGTTGCTGG-3’ 
5’-GCGCCTGCTTCCATTGGTCAGTCCT-3’ 
5’-GCGCCTGCTTTTGCTGGTCAGTCCT-3’ 
2.2.4.2 EMSA binding reaction, PAGE analysis and detection 
For binding reactions, ~2 µg whole extracts of SHSY-5Y cells or Elk1-db or YY1-db 
protein were incubated with 20 fmol biotinylated oligonucleotides in binding buffer 
(contents of binding buffer indicated in Table 2.30). In supershift assays, 300 ng of 
Tetra-His antibody (QIAGEN Inc.) was added prior to the addition of 150 ng Elk1-
db protein. 
Table 2.30: EMSA reaction buffer contents for Elk-1 and YY1 
 Elk-1 binding mix YY1 binding mix 
Contents Volume Volume 
MQ-H2O Up to 20 µl Up to 20 µl 
10X binding buffer 2 µl - 
Poly dIdC 1 µl 1 µl 
50 % glycerol 2 µl 4 µl 
20 mM EDTA 1 µl - 
6 % BSA (0,5 % for YY1) 1 µl 0.5 µl 
300 mM HEPES - 1 µl 
20 mM DTT - 1 µl 
1 mM KCl - 1.3 µl 
100 mM MgCl2 - 0.6 µl 
1 % NP-40 - 1 µl 
Protease inhibitor 1 µl 1 µl 
Unlabeled DNA 2 µl (just for competition) 2 µl (just for competition) 
WCE 2 µl 1 µl 
Biotin Labeled DNA 2 µl 2 µl 
Antibody 5 µl (for supershift) 5 µl (for supershift) 
Complexes and free DNAs were separeted on a 6 or 8 % non-denaturating 
polyacrylamide gel in 0.5X Tris-Borate-EDTA by electrophoresis for 1 h at 120 V at 
4 
o
C. The separated bands on the gel were then transferred to Biodyne A Nylon 
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Membranes (Pierce) by using Trans-Blot
®
 at 20 V for 30 min at 4 
o
C. Cross-link 
transfer of DNA to membrane was achieved by incubating the membrane with 254 
nm UV bulbs for 10 min. 
For detection step, Chemiluminescent Nucleic Acid Detection Module Kit (Pierce) 
was used, and then the membrane was exposed to X-ray ﬁlm for required amount of 
time and then developed in Kodak Medical X-ray Processor according to 
manufacturer’s instruction. In supershift assays, 300 ng of Tetra-His antibody 
(QIAGEN Inc.) was added prior to the addition of 150 ng Elk1-db protein. 
2.2.5 Dual-Luciferase Reporter Assay 
2.2.5.1 Transfection of SH-SY5Y with promoter construct plasmids and YY1 
constructs for forced experiments 
Transfection is the process to introduce a foreign DNA into the cell. For eukaryotic 
cells, lipid-cation based transfection is more typically used, because the cells are 
more sensitive. In this study, DNA was inserted into SH-SY5Y neuroblastoma cells 
by lipofection. 
In luciferase reporter assay, the amount of vector needed depends on the cell line. 
The optimal amount of control vector to use in cotransfections is the minimum 
amount that gives significant reporter activity above background (background is 
measured in samples transfected with only the test vector, pGL2-basic or pGL3-
basic). Using optimized transfection conditions for a single reporter, control vector is 
cotransfected in varying amounts. Typically a ratio of 10:1 test vector:control vector 
is used; however, 7:1 ratio of test:control vector were defined as optimum previously 
in our laboratory for SH-SY5Y neuroblastoma cell line.  
A frozen stock of SHSY-5Y cells were taken from -80 °C and after the cells were 
warmed up to room temperature they were diluted with SHSY-5Y culture media. 
After determining the cell density with hemacytometer, 50.000  cells/well were 
seeded on 24 well tissue culture plate.  Next day, 1 µg of plasmid DNAs are diluted 
in 200 µl DMEM (1X) media and vortexed and quick spun briefly. Promega’s 
transfection reagent Transfast was added to 1:3 ratio  to the DNA mixture according 
to the ratios given in the table below (Table 2.31 and Table 2.32).  
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Table 2.31: Transfection content for pGL2-S2 forced experiment. 
Construct 
name 
*pGL
2-S2 
wt-
YY1 
YY1-
woR 
YY1-
woA 
YY1-
db 
YY1-
K288
R 
pCMV
-Myc. 
pRL-
TK 
Contro
l. 
Transf
ast 
reagen
t 
pGL2-S2 700 ng - - - - - 200 ng 100 ng 3 µL 
pGL2- basic 700 ng - - - - - 200 ng 100 ng 3 µL 
pGL2-S2 
YY1 
700 ng 200 ng - - - - - 100 ng 3 µL 
pGL2- basic 
YY1 
700 ng 200 ng - - - - - 100 ng 3 µL 
pGL2-S2 
YY1-woR 
700 ng - 200 ng - - - - 100 ng 3 µL 
pGL2- basic 
YY1-woR 
700 ng - 200 ng - - - - 100 ng 3 µL 
pGL2-S2 
YY1-woA 
700 ng - - 200 ng - - - 100 ng 3 µL 
pGL2- basic 
YY1-woA 
700 ng - - 200 ng - - - 100 ng 3 µL 
pGL2-S2 
YY1-db 
700 ng - - - 200 ng - - 100 ng 3 µL 
pGL2- basic 
YY1-db 
700 ng - - - 200 ng - - 100 ng 3 µL 
pGL2-S2 
YY1-K288R 
700 ng - - - - 200 ng - 100 ng 3 µL 
pGL2-basic 
YY1-K288R 
700 ng - - - - 200 ng - 100 ng 3 µL 
Table 2.32: Transfection content for pGL3-F2 forced experiment. 
Construct 
name 
*pGL
2-F2  
wt-
YY1  
YY1-
woR  
YY1-
woA 
YY1-
db 
YY1-
K288
R 
pCM
V-
Myc. 
pRL-
TK 
Contr
ol. 
Transf
ast 
reagen
t 
pGL3-F2 700 ng - - - - - 200 ng 100 ng 3 µL 
pGL3- basic 700 ng - - - - - 200 ng 100 ng 3 µL 
pGL3-F2 
YY1 
700 ng 200 ng - - - - - 100 ng 3 µL 
pGL3- basic 
YY1 
700 ng 200 ng - - 
- - 
- 100 ng 3 µL 
pGL3-F2 
YY1-woR 
700 ng - 200 ng - - - - 100 ng 3 µL 
pGL3- basic 
YY1-woR 
700 ng - 200 ng - - - - 100 ng 3 µL 
pGL3-F2 
YY1-woA 
700 ng - - 200 ng - - - 100 ng 3 µL 
pGL3- basic 
YY1-woA 
700 ng - - 200 ng - - - 100 ng 3 µL 
pGL3-F2 
YY1-db 
700 ng - - - 200 ng - - 100 ng 3 µL 
pGL3- basic 
YY1-db 
700 ng - - - 200 ng - - 100 ng 3 µL 
pGL3-F2 
YY1-K288R 
700 ng - - - - 200 ng - 100 ng 3 µL 
pGL3-basic 
YY1-K288R 
700 ng - - - - 200 ng - 100 ng 3 µL 
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Transfection mixture was vortexed and quick spun briefly and incubated for 15 min 
at room temperature for the proper formation of DNA liposome complex. The 
growth medium was removed from the cells and the transfection mixture was added 
gently in order to prevent cell detaching and the cells returned to the 37°C %5 CO2 
incubator. After an incubation period of 90 min, the transfection mixture was 
removed and 500 µl of complete growth medium was added to each well. The cells 
were returned to the 37°C %5 CO2 incubator for 48 hours before analysis. 
2.2.5.6 Luminometrical measurement of the transfected cells   
In this study, the Dual-Luciferase® Reporter (DLR) Assay System from Promega 
was used. In the DLR Assay, the activities of firefly (Photinus pyralis) and Renilla 
(Renilla reniformis) luciferases are measured sequentially from a single sample.  
To perform the assay, 48 hours after transfection cells were harvested by lysing them 
with 60 µl 1X Passive Lysis Buffer.  The firefly luciferase reporter was measured 
first by adding 50 µl Luciferase Assay Reagent II (LAR II) to generate a stabilized 
luminescent signal. After quantifying  the firefly luminescence, this reaction was 
quenched, and the Renilla luciferase reaction is simultaneously initiated by adding 50 
µl Stop & Glo® Reagent to the same sample. The procedure was repeated for each 
sample separetly. The chemiluminescence was measured by Fluoroskan Ascent FL 
luminometre from Thermo Electron Coorporation. All transfections were performed 
as triplicates and were repeated at least two times using different DNA preperations. 
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3.  RESULTS & DISCUSSION 
3.1 Recombinant YY1-db and Elk-1-db production 
3.1.1 Cloning of YY1-db and Elk-1-db 
For 363 bp gene region corresponding to YY1 DNA binding domain (YY1-db) and 
288 bp region of Elk1 DNA binding domain (Elk-1-db) constructs were amplified 
with PCR. The resultant PCR products were run on agarose gel and the expected 
DNA fragments were detected (Figure 3.1.a lane 2 and Figure 3.2.a lane 2, 
respectively). Following PCR, DNA fragments were purified with QIAquick PCR 
purification kit and digested with appropriate restriction enzymes (BamHI-XhoI for 
Elk1-db, EcoRI-SalI for YY1-db).  
 
Figure 3.1: PCR amplification of Elk1-db and schematic representation of Elk1 
DNA binding domain. 
Amplified PCR pruducts were designed to be inserted into pET30a(+) bacterial 
expression vector. After enzyme cleavage, restricted products were purified by 
QIAquick PCR purification kit. After that, ligation procedure was performed with 
Roche T4 DNA ligase overnight at room temperature and the ligation mixture was 
then transformed into competent E. coli BL21 cells. Transformed colonies were 
selected from selective antibiotic (kanamycin) plates and colonies including Elk1-db 
and YY1-db were checked with colony PCR using forward and reverse primers of 
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the vector to verify accuracy. Agarose gel results indicated that amplicons were 
successfully ligated into vector (Figure 3.1.b and Figure 3.2.b). 
 
Figure 3.2: PCR amplification of YY1-db and schematic representation of YY1 
DNA binding domain. 
There is a 250-300 bp shift in bands when comparing primary PCR results and 
control colony PCR. The reason of the shift is due to using of vector primers, which 
span 100-150 bp from both forvard and reverse direction. After confirming the 
success of ligation, the remaining colony that was used in colony PCR, was selected 
and plasmid purification procedure was performed to collect plasmids. Collected 
plasmid DNA was subjected to sequence analysis to confirm inframe insertion and 
correct orientation. 
3.1.2 Expression of Recombinant Proteins 
In order to express Elk1-db and YY1-db, obtained construct of pET-30a-Elk1-db and 
pET-30a-YY1-db was transformed into expression strain of E.coli BL21 
(DE3)pLysS. A colony was picked from LB agar plate containing the selective 
antibiotic and dropped into LB medium. When the OD600 reached 0.6, final 
concentration of 0.5 Mm IPTG was added to bacterial culture growing in LB at 37 
o
C 
to induce protein expression.  
In order to determine the optimum expression time and the expressed recombinant 
proteins, total cell proteins were analyzed by SDS-PAGE method. For this purpose, 
bacterial samples were taken before IPTG induction (0 hour) and after IPTG 
induction at 2 hours intervals for 10 hours. Protein samples were obtained from cell 
pellets and loaded into 15 % Tricine/polyacrylamide gel (Figure. 3.3 for Elk1-db and 
3.4 for YY1-db).  
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Figure 3.3: SDS- PAGE analysis of total protein samples for Elk1-db expression 
Lane 1: SeeBlue Plus2 Prestained Protein Ladder (Invitrogen); Lane 2: pET30a-Elk-
db induced, 2 hour; Lane 3: pET30a-Elk-db induced, 4 hour;  Lane 4: pET30a-Elk-db 
induced, 6 hour; Lane 5: pET30a-Elk-db induced, 8 hour; Lane 6: pET30a-Elk-db 
induced, 10 hour  Lane 7: pET30a-Elk-db uninduced, 0 hour; 
After induction with IPTG, protein of ~17 kDa and ~23 kDa were detected for elk1-
db and YY1-db, respectively in protein samples obtained from cell pellet. The 
expression of recombinant protein increased with time slightly throughout 10 hour 
time course after IPTG induction. Although, the amount of overexpressed 
recombinant proteins seemed little at 2 hours comparing the samples taken at further 
time intervals, it is still very distinguishable. Thus, ~6 hours induction was 
performed to obtain good quality products. No expressed protein was found in the 
uninduced samples. 
 
Figure 3.4: SDS- PAGE analysis of total protein samples for YY1-db expression 
Lane 1: SeeBlue Plus2 Prestained Protein Ladder (Invitrogen); Lane 2: pET30a-YY1-
db uninduced, 0 hour Lane 3: pET30a-YY1-db induced, 2 hour; Lane 4: pET30a-
YY1-db induced, 4 hour;  Lane 5: pET30a-YY1-db induced, 6 hour; Lane 6: pET30a-
YY1-db induced, 8 hour; Lane 7: pET30a-YY1-db induced, 10 hour.  
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3.1.3 Purification of recombinant Elk1-db and YY1-db 
All purification steps were given in detail in the Materials and Methods part. At each 
purification step, the samples were taken and were further analyzed by SDS-PAGE 
method (see Figure 3.5 for Elk1-db and Figure 3.6 for YY1-db). 
 
Figure 3.5: SDS-PAGE analysis of purified Elk1-db proteins (Purified protein in 
elution fractions showed by arrows) Lane 1: SeeBlue Plus2 Prestained Protein 
Ladder; Lane 2: lysate of induced bacterial culture; Lane 3: lysate flow-through; Lane 
4: 1st wash fraction; Lane 5: 2nd wash fraction; Lane 6: 3rd wash fraction; Lane 7: 1st 
elute; Lane 8: 2nd elute; Lane 9: 3rd elute; Lane 10: 4th elute 
Distinct protein bands were seen in elution fractions clearly and the protein amount 
decreased gradually in elution steps. In order to check whether the purified protein is 
the same as the overexpressed one, the control sample containing total protein 
fraction from bacterial cultures was applied to the SDS-PAGE gel as well. In 
addition, the overexpressed recombinant Elk1-db and YY1-db protein bands were 
observed in bacterial cell lysate sample and this band was missing in the flow- 
through sample because overexpressed proteins bound to Ni-NTA agarose with its 
His-tags during purification process. In wash fractions, desired protein bands were 
not observed as expected. 
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Figure 3.6: SDS-PAGE analysis of purified YY1-db proteins (Purified protein in 
elution fractions showed by arrows) Lane 1: SeeBlue Plus2 Prestained Protein 
Ladder; Lane 2: lysate of induced bacterial culture; Lane 3: lysate flow-through; Lane 
4: 1st wash fraction; Lane 5: 2nd wash fraction; Lane 6: 3rd wash fraction; Lane 7: 1st 
elute; Lane 8: 2nd elute; Lane 9: 3rd elute; Lane 10: 4th elute 
3.2 Determination of Elk1 and YY1 binding sites on SPG4 and KATNB1 
promoter regions by EMSA 
3.2.1 Identification of Elk1 and YY1 binding sites on the optimal SPG4 
promoter 
Based on its functions in neuronal tissues, we theoretically searched the presence of 
Elk1 and YY1 transcription factors binding sites in the SPG41 promoter by using 
PROMO bioinformatics tool (Messeguer et al. 2003; Farre et al. 2003) restricting the 
maximum matrix dissimilarity rate 0-3% for Homo sapiens. According to these 
search results, three Elk1 binding sites (positioned at -1074/-1066, -451/-443, and -
235/-227) and one YY1 binding site (-614/-610) have been predicted in the promoter 
(see Appendix A). 
Electrophoretic mobility shift assay (EMSA) was performed in order to conﬁrm the 
binding of Elk1 transcription factor to its predicted sites on the optimal promoter of 
SPG4 gene (S2 construct containing the region at -921/-221). For this purpose, we 
chose two predicted binding site for Elk1 based on their locations in the critical 
promoter sites that we identiﬁed, and these sites are positioned at -451/-443 and -
235/-227.  
Protein binding to Elk1 and YY1 binding site (WT) was observed using both SH-
SY5Y whole cell extract (WCE) (Figure 3.7.a and b -lane 2 and Figure 3.8 for Elk1 
and YY1 respectively) and pure Elk1-db and YY1-db protein (Figure 3.9 and Figure 
3.10 –lane 1). The signal shifts of the DNA-protein interactions were prevented when 
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Elk1 oligo mutated in their binding site (Mut) was used with WCE (Figure 3.7.a-b 
and Figure 3.8 -lane 4) and with Elk1-db (Figure 3.9 and Figure 3.10 -lane 3).  
 
Figure 3.7: Determination of Elk1 binding sites on the SPG4 promoter by EMSA 
We also performed competition analysis using non-labeled WT-Elk1 oligos (1000 
fold molar excess) and the band shift was lost (Figure 3.7.a-b and Figure 3.8 -lane 5).  
 
Figure 3.8: Determination of YY1 binding sites on the SPG4 promoter by EMSA. 
 Recombinant His-tagged Elk1 protein interaction was supershifted using anti-His 
antibody (Figure 3.9 -lane 2-4 and Figure 3.10 -lane 2) and no supershift was 
observed when mutated Elk1 and YY1 oligos used (Figure 3.9.-lane 5-7 and Figure 
3.10 -lane 4) 
 45 
 
Figure 3.9: Determination of specificity of Elk1 binding to KATNB1 promoter by 
EMSA using purified recombinant proteins. 
 
 
Figure 3.10: Determination of specificity of YY1 binding to SPG4 promoter by 
EMSA using purified recombinant proteins. 
3.2.2 Identification of Elk1 and YY1 binding sites on the optimal KATNB1 
promoter 
The presence of Elk1 and YY1 transcription factors binding sites in the KATNB1 
promoter was predicted by using PROMO bioinformatics tool restricting the 
maximum matrix dissimilarity rate 0-3% for Homo sapiens. According to these 
search results, only one Elk1 binding site positioned at -531/-523 and two YY1 
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binding sites with CCAT/ATGG consensus sequence have been predicted in the 
promoter (see Appendix B).  
To confirm the binding of Elk1 and YY1 transcription factors to their predicted sites 
on the optimal promoter of KATNB1 gene (F2 construct containing the region at -
892/-375) EMSA was performed (Figure 3.11.a and Figure 3.12.a-b for Elk1 and 
YY1 respectively). Protein binding to Elk1 binding site (WT) was observed using 
both SH-SY5Y whole cell extract (WCE) (Figure 3.11.a -lane 2) and pure Elk1-db 
protein (Figure 3.11.b –lane 1). The signal shifts of the DNA-protein interactions 
were prevented when Elk1 oligo mutated in their binding site (Mut) was used with 
WCE (Figure 3.11.a -lane 4) and with Elk1-db (Figure 3.11.b -lane 3). We also 
performed competition analysis using non-labeled WT-Elk1 oligos (1000 fold molar 
excess) and the band shift was lost (Figure 3.11.a -lane 5). Recombinant His-tagged 
Elk1 protein interaction was supershifted using anti-His antibody (Figure 3.11.b -
lane 2) and no supershift was observed when mutated Elk1 oligo used (Figure 3.11.b 
-lane 4).  
 
Figure 3.11: Determination of Elk1 binding sites on the KATNB1 promoter and 
specifying of binding using recombinant protein by EMSA. 
Protein bindings to YY1 binding sites (WT-1 and WT-2) were observed using both 
SHSY-5Y whole cell extract (WCE) (3.12.a -lane 2 and 3.12.b -lane 2) and pure 
Elk1-db protein (3.13.a -lane 1 and 3.13.a 1). The signal shifts of the DNA-protein 
interactions were prevented when YY1 oligos mutated in their binding sites (Mut-1 
and Mut-2) were used with WCE (3.12.a -lane 4 and 3.12.b -lane 4) and with Elk1-
db (3.13.a -lane 3 and 3.13.b -lane 3). In competition analysis, the band shifts were 
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Figure 3.12: Determination of YY1 binding sites on the KATNB1 promoter by 
EMSA 
lost (3.12.a -lane 5 and 3.12.b -lane 5). The supershifted bands were observed (3.13.a 
-lane 2 and 3.13.b -lane 2) and the supershift was lost when mutated YY1 oligos used 
(3.13.a -lane 4 and 3.13.b -lane 4). 
 
Figure 3.13: Determination of specificity of YY1 binding to KATNB1 promoter by 
EMSA using purified recombinant proteins. 
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3.3 Luminometrical Measurements Data of Promoter Constructs (F2 and S2) 
3.3.1 Cloning of YY1 constructs (YY1-woA, YY1-woR) 
For 777 bp gene region corresponding to YY1 protein that lacking activator domain 
(YY1-woA), 468 bp gene region related to upstream of YY1 repressor domain 
(YY1-woR1) and 639 bp gene region related to downstream of YY1 repressor 
domain (YY1-woR2) constructs were amplified with PCR. The resultant PCR 
products were run on agarose gel and the expected DNA fragments was detected 
(Figure 3.14.a). Following PCR, DNA fragments were purified with QIAquick PCR 
purification kit and digested with appropriate restriction enzymes (KpnI-BamHI for 
YY1-woa, EcoRI-KpnI for YY1-woR1 and KpnI-BamHI for YY1-woR2).  
 
 
Figure 3.14: PCR amplification of YY1 constructs. a) PCR amplification of YY1-
woa (lane2), YY1-woR1 (lane3) and YY1-woR2 (lane4) prior to 
enzyme digestion. b) colony PCR of YY1-woA and YY1-woR1. c) 
colony PCR of YY1-woR (includes YY1-woR1 and YY1-woR2) 
Amplified PCR pruducts were designed to be inserted into pCMV6 mammalian 
expression vector. After enzyme cleavage, restricted products were purified by 
QIAquick PCR purification kit. After that, ligation procedure was performed with 
Roche T4 DNA ligase overnight at room temperature and the ligation mixture was 
then transformed into competent E. coli DH5α cells. Transformed colonies were 
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selected from selective antibiotic (ampicillin) plates and colonies including YY1-woa 
and YY1-woR1 (Figure 3.14.b) were checked with colony PCR using forward and 
reverse primers of the vector to verify accuracy. To obtain YY1 construct that lacks 
repression domain, amplicons covering YY1-woR1 and YY1-woR2 ligated into 
vector sequentially. Ligated two pieces were confirmed by colony PCR (Figure 
3.14.c) Agarose gel results indicated that amplicons were successfully ligated into 
vector.  
After confirming the success of ligation, the remaining colony that was used in 
colony PCR, was selected and plasmid purification procedure was performed to 
collect plasmids. Collected plasmid DNA was subjected to sequence analysis to 
confirm inframe insertion and correct orientation. 
3.3.2 Production of Mutant YY1 (YY1-K288R)  
In order to introduce mutation to YY1 residue 288, mutation primers, which convert 
lysine 288 to arginine, were used. Following PCR, mutated plasmids were purified 
and transformed into E. coli DH5α strain. Then amplified plasmids were directly 
used for sequence analysis to confirm the presence of desired mutation. Sequence 
analysis showed that lysine residue at position 288 was successfully subsituted with 
arginine (Figure 3.15).  
 
 
Figure 3.15: Sequence analysis of mutant YY1 
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3.3.3 Luminometrical  Measurement of Data of YY1 constructs for KATNB1 
gene promoter 
SH-SY5Y neuroblastoma cells were co-transfected with both F2 construct containing 
KATNB1 core promoter and wt-YY1, or F2 and YY1-db or F2 and YY1-woR or F2 
and YY1-woA or F2 and YY1-K288R, respectively. As control only F2 construct 
was transfected. All experiments were repeated 3 times on separate day as triplicates. 
Light units of independent experiments are given in table 3.1, 3.2 and 3.3. 
Table 3.1: Measured light units of experiment n=1for KATNB1 promoter 
N=1 F2 
F2  
Basic 
YY1 
YY1 
Basic 
YY1-
db 
YY1-
db 
basic 
YY1-
woR 
YY1-
woR 
basic 
YY1-
woA 
YY1-
woA 
basic 
YY1-
mut 
YY1-
mut 
basic 
1 
Firefly 18,87 0,5467 4,928 0,5767 18,63 0,4175 2,79 0,0599 3,208 0,2309 9,936 0,4937 
Renilla 1,449 2,249 4,934 4,648 2,919 3,731 1,02 0,9841 2,353 3,129 4,572 3,308 
2 
Firefly 14,25 0,5956 7,698 0,5414 14,97 0,383 2,495 0,0728 3,09 0,2121 11,62 0,5291 
Renilla 1,394 2,669 5,068 4,484 2,306 3,816 1,227 1,097 2,519 2,956 4,694 4,353 
3 
Firefly 19 0,5361 5,792 0,431 14,37 0,5109 2,686 0,1057 3,302 0,241 11,35 0,4289 
Renilla 1,578 2,063 3,876 3,646 2,935 3,814 1,011 1,384 2,744 3,315 4,152 3,283 
Table 3.2: Measured light units of experiment n=2for KATNB1 promoter 
N=2 F2 
F2  
Basic 
YY1 
YY1 
Basic 
YY1-
db 
YY1-
db 
basic 
YY1-
woR 
YY1-
woR 
basic 
YY1-
woA 
YY1-
woA 
basic 
YY1-
mut 
YY1-
mut 
basic 
1 
Firefly 12,42 0,3749 6,931 0,2427 12,01 0,1868 3,371 0,0468 3,554 0,1201 11,28 0,4355 
Renilla 0,9124 1,741 4,33 3,32 1,75 2,838 1,017 0,9356 2,645 2,02 4,775 5,448 
2 
Firefly 16,39 0,3889 6,351 0,2528 16,79 0,2474 2,794 0,0348 2,92 0,1414 11,74 0,4944 
Renilla 1,592 1,694 3,319 3,053 3,682 2,916 0,6478 0,6136 1,622 1,985 4,526 4,691 
3 
Firefly 16,59 0,3383 4,263 0,292 12,92 0,211 2,281 0,0309 2,86 0,1426 10,51 0,4914 
Renilla 1,506 1,545 1,48 3,272 2,182 2,319 0,7765 0,7121 2,16 2,136 4,086 5,094 
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Table 3.3: Measured light units of experiment n=3for KATNB1 promoter 
N=1 F2 
F2  
Basic 
YY1 
YY1 
Basic 
YY1-
db 
YY1-
db 
basic 
YY1-
woR 
YY1-
woR 
basic 
YY1-
woA 
YY1-
woA 
basic 
YY1-
mut 
YY1-
mut 
basic 
1 
Firefly 8,487 0,1507 4,917 0,2116 13,44 0,1689 4,509 0,1054 4,188 0,1231 5,377 0,2303 
Renilla 0,3262 0,4805 1,438 1,131 0,6079 1,286 0,2963 0,7891 0,6492 0,9627 1,193 1,106 
2 
Firefly 12,64 0,1152 6,095 0,2209 8,373 0,2482 5,777 0,0832 4,877 0,1128 6,243 0,2411 
Renilla 0,3252 0,4231 1,358 1,028 0,4839 1,513 0,3541 0,4432 0,6593 0,8364 1,255 1,498 
3 
Firefly 11,57 0,1507 6,742 0,2706 15,57 0,2291 3,643 0,0647 4,597 0,2272 5,668 0,1207 
Renilla 0,3085 0,4649 2 1,143 0,6002 1,553 0,2507 0,567 0,6897 1,335 0,8287 0,8873 
 
The following equation is used to determine the normalized fold change in activity 
between test groups, considered as fold of induction in respect to the activity of the 
empty vector pGL3-Basic. Fold activity results for all 3 experiments are shown in 
Figure 3.16.   
                             (3.1) 
 
 
Figure 3.16: Average fold activities of YY1 constructs forced experiment on 
KATNB1 core promoter.  
= 
_______________________________ 
   Average (Firefly/Renilla) pGL2-Basic 
Average (Firefly/Renilla) Sample X 
Δ Fold Activation 
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According to these data, wt-YY1 acts as a repressor on KATNB1 promoter. When the 
repressor domain of YY1 was excluded, repressive properties of YY1 was abolished. 
The reason of repression could be the recruitment of histone deacetylases to the 
proximity of the basal transcriptionan apparatus due to the interactions between 
HDACs and YY1 repressor domain.  
Similar to YY1-woR, the YY1-db elevated the expression level. As stated by Austen 
et al. (1997), YY1-db with a spacer sequence, which resides between DNA binding 
and repression regions, decreased the expression level. However, in this study, YY1-
db construct increased the expression level. Lysine 288, which reside in the spacer 
region, could be SUMOylated so that  it might cause repression. However, YY1-db 
used in this study lacks of SUMOylation site and this might be the reason for 
increased expression level. Moreover, as stated in Rizkallah and Hurt (2009), the 
YY1 DNA-binding region includes phosphorylation sites; threonine 348, and 378. 
Phosphorylation of these residues cause the loss of YY1 DNA-binding activity. YY1 
domains excluding DNA binding region, may in charge of recruitment of 
phosphatases to dephosphorylate residues on DNA binding region in order to recover 
YY1 DNA-binding activity. In our case, YY1-db which has only DNA-binding 
domain may not interact with phosphatases and not able to dock on target DNA so 
that cannot show repressive activity. 
Although we were expecting the lowest activity for YY1-woA expressing cells, 
surprisingly the level of expression was higher than wt-YY1 expressing cells. Thus, 
activation domain of YY1 may interact with co-repressors. Further identification of 
YY1 interacting partners remains to be elucidated. 
Furthermore, to investigate effect of SUMO modification, lysine 288 was converted 
to arginine because SUMO-modified proteins accept SUMO modification on lysine 
residue. According to luminometrical measurement data we can conclude that 
SUMO defficient YY1 increased expression level slightly but not as much as YY1-
woR did. Hence, glycine/lysine rich R domain of YY1 may contribute to major 
repression activity. Another possibility is that, most SUMO-modified proteins 
contain the consensus motif ψKxE but, identified YY1SUMOylation site does not 
contain this motif and far from the gylcine/lysine (G/K) rich domain of YY1. So that, 
G/K rich region may have additional SUMOylation site that can be further 
investigated.  
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3.3.4 Luminometrical  Measurement of Data of YY1 constructs for SPG4 gene 
promoter 
SH-SY5Y neuroblastoma cells were co-transfected with both S2 construct containing 
SPG4 core promoter and wt-YY1, or S2 and YY1-db or S2 and YY1-woR or S2 and 
YY1-woA or S2 and YY1-K288R, respectively. As control only S2 construct were 
transfected. All experiments were repeated 3 times on separate day as triplicates. 
Light units of independent experiments are given in table 3.4, 3.5 and 3.6.  
Table 3.4: Measured light units of experiment n=1 for SPG4 promoter 
N=1 F2 F2  
Basic 
YY1 YY1 
Basic 
YY1-
db 
YY1-
db 
basic 
YY1-
woR 
YY1-
woR 
basic 
YY1-
woA 
YY1-
woA 
basic 
YY1-
mut 
YY1-
mut 
basic 
1 Firefly 0,627
9 
0,006
2 
0,970
3 
0,01 1,6 0,003
5 
1,197 0,009
2 
0,727
6 
0,006
7 
0,931
8 
0,009
6 
Renill
a 
0,317
2 
0,304
8 
0,828
6 
0,799
4 
0,996
6 
0,542
5 
0,377 0,265
9 
1,229 0,371
9 
0,756
4 
0,779
4 
2 Firefly 0,811
2 
0,003 1,151 0,014
7 
1 0,007
5 
0,878
5 
0,003
5 
0,512
4 
0,002
8 
0,651
8 
0,010
4 
Renill
a 
0,300
9 
0,201
1 
0,863
2 
0,636
8 
0,716
1 
0,477
7 
0,213
3 
0,245
4 
0,823
7 
0,400
2 
0,684
9 
0,556
3 
3 Firefly 0,992 0,01 1,289 0,014
5 
1,185 0,001 0,620
4 
0,000
3 
0,641
1 
0,006
5 
0,902
8 
0,007
9 
Renill
a 
0,208
9 
0,207
2 
0,750
5 
0,764
2 
0,578
6 
0,402
9 
0,259
6 
0,162
2 
0,893
4 
0,275
1 
0,637
6 
0,703
8 
 
Table 3.5: Measured light units of experiment n=2 for SPG4 promoter 
N=2 S2 
S2  
Basic 
YY1 
YY1 
Basic 
YY1-
db 
YY1-
db 
basic 
YY1-
woR 
YY1-
woR 
basic 
YY1-
woA 
YY1-
woA 
basic 
YY1-
mut 
YY1-
mut 
basic 
1 
Firefl
y 
1,510
0 
0,018
3 
0,915
6 
0,035
3 
1,612
0 
0,018
0 
0,190
8 
0,003
2 
0,411
3 
0,014
0 
0,821
0 
0,027
3 
Renill
a 
1,473
0 
1,891
0 
3,461
0 
3,764
0 
2,946
0 
2,464
0 
0,620
0 
0,993
4 
1,692
0 
2,451
0 
3,193
0 
3,260
0 
2 
Firefl
y 
1,989
0 
0,027
2 
1,245
0 
0,031
0 
1,297
0 
0,018
4 
0,429
7 
0,003
7 
0,511
8 
0,010
4 
0,888
6 
0,043
8 
Renill
a 
1,659
0 
2,121
0 
4,940
0 
3,171
0 
2,416
0 
2,775
0 
1,154
0 
1,046
0 
1,751
0 
2,154
0 
3,549
0 
5,839
0 
3 
Firefl
y 
1,687
0 
0,022
0 
0,938
3 
0,027
2 
1,517
0 
0,018
1 
0,320
5 
0,007
4 
0,596
7 
0,014
9 
1,107
0 
0,035
1 
Renill
a 
1,470
0 
2,023
0 
3,743
0 
2,626
0 
2,448
0 
2,367
0 
0,906
1 
1,090
0 
2,038
0 
1,823
0 
4,324
0 
4,015
0 
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Table 3.6: Measured light units of experiment n=3 for SPG4 promoter 
N=3 S2 
S2  
Basic 
YY1 
YY1 
Basic 
YY1-
db 
YY1-
db 
basic 
YY1-
woR 
YY1-
woR 
basic 
YY1-
woA 
YY1-
woA 
basic 
YY1-
mut 
YY1-
mut 
basic 
1 
Firefl
y 
1,883
0 
0,007
7 
1,134
0 
0,028
6 
1,051
0 
0,015
2 
0,867
9 
0,008
0 
0,933
7 
0,013
7 
1,302
0 
0,021
6 
Renill
a 
0,830
8 
0,499
4 
1,768
0 
2,365
0 
0,534
7 
1,286
0 
0,540
9 
0,689
4 
1,175
0 
1,361
0 
1,867
0 
1,469
0 
2 
Firefl
y 
1,176
0 
0,012
2 
1,286
0 
0,036
7 
1,497
0 
0,018
3 
0,751
8 
0,010
2 
0,760
3 
0,018
4 
1,220
0 
0,021
6 
Renill
a 
0,444
2 
0,726
9 
1,959
0 
1,632
0 
1,018
0 
1,713
0 
0,814
6 
0,708
1 
1,564
0 
1,117
0 
1,375
0 
1,578
0 
3 
Firefl
y 
0,813
0 
0,014
9 
1,642
0 
0,033
0 
2,206
0 
0,011
9 
0,953
1 
0,008
4 
0,941
2 
0,016
0 
1,249
0 
0,015
3 
Renill
a 
0,247
6 
0,740
9 
2,295
0 
2,119
0 
1,618
0 
1,310
0 
0,910
9 
0,794
0 
1,499
0 
1,375
0 
2,128
0 
1,601
0 
The equation (3.1) was used to determine the normalized fold change in activity 
between test groups, considered as fold of induction in respect to the activity of the 
empty vector pGL2-Basic. Graph of average of the calculated fold activity of all 3 
experiments are shown in Figure 3.16. 
 
 
Figure 3.17: Average fold activities of YY1 constructs forced experiment on SPG4 
core promoter. 
 
Results of experiments demonstrated that YY1 constructs had similar effect on SPG4 
promoter as seen in KATNB1. wt-YY1 acts as a repressor on KATNB1 promoter. 
When the repressor domain of YY1 was excluded, repressive properties of YY1 was 
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abolished. Again the YY1-db elevated the expression level. Similar to YY1-woA 
effect on SPG4 promoter, KATNB1 promoter activity was elevated compared to 
YY1-db. According to luminometrical measurement data we can conclude that 
SUMO defficient YY1 increased expression level slightly but this increment was not 
significant statistically compared to wt-YY1.  
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4.  CONCLUSION 
Both Elk1 and YY1 can act as repressor or activator on gene promoters. Their 
fuction on KATNB1 and SPG4 promoters has not been studied. This study is the first 
report on regulation of KATNB1 and SPG4 gene promoters by Elk1 and YY1 
transcription factors.  
After confirming exact binding of YY1 to KATNB1 and SPG4 promoters, how YY1 
regulates spastin and katanin expression remains to be elucidated.  To illuminate this 
obscurity, we produced different YY1 constructs lacking funtional domains. The 
results demonstrated that YY1 acts as repressor on both KATNB1 and SPG4 
promoters. SUMO-modification of YY1 was not effective on YY1 repressor activity. 
Major  repressor function of YY1 was probably due to its glycine/lysine rich domain. 
Finally, both KATNB1 and SPG4 promoters contain functional CpG islands. It is well 
known that methylation of these CpG islands affect gene expression. Hence, CpG 
islands in KATNB1 and SPG4 promoters may also alter expression level of katanin-
p80 and spastin. 
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